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ABSTRACT 
 
MATERNAL NICOTINE EXPOSURE DURING GESTATION AND LACTATION 
INDUCE PREMATURE AGING OF THE LUNGS OF THE OFFSPRING 
 
M Mutemwa 
MSc thesis, Department of Medical Biosciences, University of the Western Cape. 
 
Tobacco smoking remains one of the leading causes of death worldwide. Despite 
all the efforts made by governments, researchers and communities to educate 
women about the dangerous effects of tobacco smoke and nicotine, smoking 
during pregnancy continues to be a common habit and accounts for a significant 
percentage of fetal morbidity and mortality. The offspring is, as a result, exposed 
to nicotine through the blood and the milk of the mother. Nicotine is therefore 
expected to interact with the developing fetus and the offspring of mothers who 
smoke or use Nicotine Replacement therapy for smoking cessation, resulting in 
the interference with normal fetal lung development. Maternal cigarette smoke or 
nicotine exposure produces adverse effects in the lungs of offspring, these 
include; intrauterine growth retardation, low birth weight, premature birth, 
reduced pulmonary function at birth, and a high occurrence of respiratory 
illnesses after birth. The main objectives of this study were to determine: 1) the 
effects of maternal nicotine exposure during gestation and lactation on lung 
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development in the offspring, 2) if there is evidence of premature aging of the 
lungs of the lungs of the nicotine exposed offspring, and 3) whether tomato juice 
can have protective effects on the fetal lung development and function in the 
offspring. From the study, it was established that maternal nicotine exposure had 
no significant effect on the growth parameters of the offspring. However, it results 
in the late onset of gradual parenchymal damage which resembles premature 
aging. The study also found that the consumption of tomato juice may have 
protective effects on the premature aging of the lungs of the offspring. 
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CHAPTER 1 
Literature Review 
1.1 LUNG DEVELOPMENT 
The adequate development and maturation of the lung, particularly during the 
prenatal stage of fetal development, is extremely important given that the survival 
of the infant at birth is dependent on this process (Copland and Post, 2004). 
 
It has been reported that premature birth occurs in about 5 to 10% of all 
pregnancies. According to researchers, one of the main problems with premature 
birth appears to be the immaturity of the lung. The inadequate development of 
the lung causes approximately 75% of early mortality and long-term disability in 
prematurely born infants. The infants that have extremely low birth-weights, born 
between 24 and 28 weeks of gestation are the most susceptible to lung injury 
(Stevenson et al, 1998) because their lungs are fragile and have small volumes 
for gaseous exchange (Copland and Post, 2004). 
 
Human lung development begins around day 26 of gestation, which is 
approximately the fourth week after conception. It includes the increase in the 
number of mature alveoli and continues postnatally until around the age of 7 
(Boyden, 1977; Crapo et al, 1980; Jeffery, 1998).  The main stages of lung 
development begin around week 8 and continue till week 40 of gestation ( which 
is about 32 weeks). The 32 weeks of development during the gestation period 
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are categorized into phases according to the visual appearance of lung tissue 
(Boyden, 1977). Normal lung development, which occurs as a series of complex, 
tightly regulated events, can be divided into five phases (Joshi and Kotecha, 
2007). These phases include the embryonic phase, the pseudoglandular phase, 
the canalicular phase, the saccular phase, and the alveolar phase (Haddad, 
2002). 
 
1.1.1 Embryonic Stage 
The embryonic phase of human lung development begins around the 4th week 
(day 26) of gestation in humans and continues until the 6th week (day 52) of 
gestation. This phase begins with the emergence of the lung from the base of the 
primordial foregut endoderm as the laryngo-tracheal groove (Ornitz et al, 1996; 
Cardoso, 2000). This forms the trachea and bronchial buds, which consecutively 
expands at the beginning of week 5 to form the main bronchi. The embryonic 
phase is mainly identified by the development of the lobular segments of the 
respiratory tree as tubes lined with columnar epithelium. The columnar epithelium 
is noticeable by the end of week 5 or 6 (Boyden, 1977). 
 
1.1.2 Pseudoglandular Stage 
The subsequent phase is the pseudoglandular phase which begins around week 
5 or 6 (that is about day 52) and continues till week 16 or 17 of gestation. This 
phase is identified by the development of the fetal lungs as an exocrine gland 
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and the completion in the growth of the primal airways. During this phase, 
cartilage appears around the larger airways; smooth muscles also begin to 
evelop airways and blood vessels. At the end of this phase, acinar outlines first 
begin to appear as epithelial tubes and then continue to grow and branch. The 
columnar epithelial cells lining the tubular glandular structures that did not 
differentiate evolve into the many cell types that occupy the airways. These cells 
include serous, goblet, ciliated, clara and alveolar cells (Boyden, 1977; Mason 
and Williams, 1977; Crapo et al, 1980). 
 
1.1.3 Canalicular Stage 
The canalicular phase commences around week 16 or 17 of gestation and 
carries on until the 25th to the 27th week of gestation.  This phase includes major 
developments of the fetal lung that are crucial to the extra-uterine life. These 
major developments include the enlargement of the lumina of the bronchi, and 
the terminal bronchioles, the development of capillaries at the site of the future 
air space where the alveoli would later form, and the appearance of surfactant.  
The subdivisions of the acini are also formed at this stage. Furthermore the lining 
of the epithilium begins to differentiate into alveolar type I and type II cells 
(Boyden, 1977; Mason and Williams, 1977) and the production of surfactant 
components by type II cells which are evident in the form of lamellar inclusion 
bodies by the 24th week of gestation (Kotecha, 2000). 
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1.1.4 Saccular Stage 
The saccular or terminal sac phase begins around the 28th week of gestation and 
continues to about the 35th week of gestation.  The phase is identified by the 
development of the terminal air sacs from alveolar ducts, refinement of the areas 
of gaseous exchange, a reduction in the thickness of the interstitial tissue, the 
thinning of the epithelium, the separation of the terminal air spaces as well as the 
differentiation of the terminal stages of alveolar type I and type II epithelial cells 
(Haddad, 2002). 
 
1.1.5 Alveolar Stage 
The ultimate phase is the alveolar phase which occurs during the last 5 weeks of 
fetal lung development. This phase begins at around the 36th week of gestation 
and is identified by the formation and maturation of the alveoli (Kotecha, 2000). 
During this phase, millions of alveoli are formed, with the interval surface area of 
the lung increased by thinning of the septal walls and reduction in the cuboidal 
epithelium. The phase further includes the separation of terminal subsaccules by 
loose connective tissue and the continuation of cellular maturation, more 
particularly alveolar type II epithelial cells which develop a greater density of 
lamellar bodies (Boyden, 1977; Mason and Williams, 1977).  Further key 
determinants for lung development and maturation include maintenance of 
sufficient fetal lung fluid volume and fetal breathing movements, which appear to 
be crucial for the normal development of the lung (Kotecha, 2000). 
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1.2 FACTORS AFFECTING LUNG DEVELOPMENT 
Despite efforts made by modern management, disorders of lung development 
and maturation together with the control of breathing, still remain central 
challenges that confront neonatologists today (Copland and Post, 2004). The 
normal development of the lung can be affected by various factors that are 
interrelated. These factors include factors that can be developmental, genetic, 
environmental or mechanical.  Examples of these range from maternal and fetal 
nutrition, endocrine factors, fetal breath movements, normal fetal lung fluid 
production, sufficient amniotic fluid volume, adequate intrathoracic and 
extrathoracic space, positive transpulmonary pressure, to normal postnatal 
adaptation (Mesas-Burgos et al, 2009). 
 
1.3 EMPHYSEMA 
Emphysema is an important component of chronic obstructive pulmonary 
disease (COPD). It is a highly prevalent pulmonary disease (Snider et al, 1985) 
which is one of the major causes of morbidity and mortality worldwide (Harrison 
et al, 1997). Emphysema has been defined as a chronic and terminal disease in 
which the distal air spaces of the terminal bronchiole are abnormally and 
permanently enlarged.  This abnormal enlargement of the air spaces is caused 
by the destruction of alveolar walls (Snider et al, 1985) which results in the 
restriction of airflow and the disturbance in blood oxygenation (Shapiro, 1995). 
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Although the pathogenesis of emphysema still remains unknown, a number of 
studies have proposed that genetic factors may have a role to play in determining 
individual susceptibility to the development of emphysema (Ito et al, 2005). The 
development of emphysema has been linked with smoking and atmospheric 
pollution by many researchers (Snider et al, 1985). Historically, emphysema has 
been linked to an excessive lung inflammation caused by the chronic inhalation of 
cigarette smoke and the resultant protease/anti-protease imbalance (Shapiro, 
1995). It has been proposed that the destruction of tissue, which is a distinctive 
characteristic of emphysema, directly causes a decrease in lung tissue density. 
However, further loss of the tissue density comes from lung hyperinflation that is 
a result of enlarged lung compliance (Dirksen et al, 1997). 
 
Studies have been done on lung changes that are characteristic of emphysema 
in both humans and animals through the use of different methodologies (Starcher 
and Williams, 1989; Janoff et al, 1983). A good number of these studies propose 
that connective tissue, particularly elastin, is the main target of the destruction 
observed in emphysema. It is generally believed that the structural 
rearrangement and loss of gaseous exchange surface brought about by elastin 
degradation in emphysema is permanent (Mercer and Crapo, 1992). 
 
There is also increasing evidence in involvement of alveolar cell apoptosis in the 
pathogenesis of emphysema (Rangasamy et al, 2004). Since emphysema is 
characterized by a progressive impairment in alveolar gaseous exchange, which 
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is most likely a consequence of loss of alveolar capillaries, it has been suggested 
that there is a potential link between alveolar cell apoptosis and disruption of 
molecular and cellular signaling involved in alveolar structural maintenance and 
repair. This potential link has broader implications since the pathogenesis of 
alveolar damage induced by cigarette smoke may have common characteristics 
with alveolar enlargement due to aging (Tuder et al, 2006). 
 
Pathologists have distinguished two major forms of emphysema which are 
closely related (Friedman, 2008). The first of these is centrilobular emphysema 
which is the most commonly observed form of emphysema. This form of 
emphysema is predominantly associated with the prolonged exposure to 
cigarette smoke (McCusker, 1992; Pryor et al, 1983). It is characterized by the 
breakdown of alveolar walls in the central portion of the acini, initially sparing the 
peripheral parts of the acinus and lobule.  This form of emphysema is generally 
manifested in the upper regions of the lung.  Panlobular emphysema on the other 
hand is recognized by the destruction involving all portions of the lobule out to 
the periphery, and is usually more severe in the lower lung regions (Friedman, 
2008). It is further characterized by airspace enlargement throughout the acinus 
and is generally a consequence of a deficiency in the production of α1-protease 
inhibitor (McCusker, 1992). 
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1.4 THE PROTEINASE-ANTIPROTEINASE THEORY  
Several studies have indicated that protease pathogenesis has an influence in a 
number of lung diseases, including asthma and COPD (Demedts et al, 2006); a 
disease characterized by the impairment of air flow (Eriksson, 1999). Generally, 
there appears to be a disturbance in the balance between proteolytic and anti-
proteolytic molecules in lungs of patients with COPD (Demedts et al, 2006), 
resulting in an elevated proteolytic activity causing damage of healthy lung 
parenchyma, initiating the progression of emphysema. The increase in proteolytic 
activity may be a result of inflammation, which is characterized by the release of 
proteolytic enzymes by inflammatory cells such as macrophages and neutrophils, 
or could otherwise be a consequence of genetic factors such as deficiency of 
alpha-1 antitrypsin (Demedts et al, 2006). 
 
The imbalance between proteases and anti-proteases results in the destruction 
of alveolar walls, thus developing into emphysema. Furthermore oxidative stress 
influences the proteinase-antiproteinase imbalance by stimulating proteases and 
inactivating antiproteinases. In addition to this, oxidants have an important role to 
play in the inflammatory reaction by stimulating the transcription factor (NF-κB), 
hence stimulating the transcription of pro-inflammatory genes (Demedts et al, 
2006). 
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1.5 OXIDANT-ANTIOXIDANT STATUS 
Oxidative stress is primarily caused by the imbalance between the production of 
reactive oxygen species (ROS) and the biologic scavenger system which 
detoxifies the reactive oxygen intermediates under normal physiologic conditions. 
Oxidative stress can also influence the molecular mechanisms that control lung 
inflammation (Guo and Ward, 2007). 
 
The epithelium of the lung is frequently exposed to oxidants produced internally 
as part of normal metabolism, as well as oxidants in the ambient air, including 
ozone, nitrogen dioxide, diesel exhaust, and cigarette smoke (Rahman et al, 
2006). A large amount of oxygen passes through the lung causing the lung to be 
highly susceptible to oxidative stress. Various levels of antioxidants are therefore 
required for protection against these vulnerabilities (Arab et al, 2002).  
 
The main oxidants that are found in the lung are reactive oxygen species which 
include superoxide, hydrogen peroxide, and hydroxyl radicals; and the reactive 
nitrogen species (RNS) which include nitric oxide (NO) and its derivates 
peroxynitrite (ONOO-) and nitrogen dioxide. These oxidative and nitrosative 
species are the primary contributors to inflammatory injury (Lang et al, 2002). 
Molecules such as protein and lipid peroxide radicals can also contribute to 
oxidative stress (Musellim et al, 2006). The major oxidant sources in the lungs 
include neutrophils, eosinophils and alveolar macrophages, alveolar epithelial 
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cells, bronchial epithelial cells and endothelial cells. The formation of these 
oxidants is exacerbated by exposure to exogenous chemical and physical agents 
such as mineral dusts, ozone, nitrogen oxides, ultraviolet and ionizing radiation 
and tobacco smoke (De Paepe et al, 1999). Oxidative stress can lead to 
peroxidation of membrane lipids, reduction of nicotinamide nucleotides, rises in 
intracellular calcium ions, cytoskeleton disruption and deoxyribonucleic acid 
(DNA) damage (Foronjy and D'Armiento, 2006; Musellim et al, 2006). This 
subsequently results in an impaired cellular function, induces apoptosis, and 
stimulates dysfunctional matrix remodeling (Foronjy and D’Armiento, 2006).  
 
According to what Harman (1956) suggested in the free radical theory of aging, 
oxidative stress is responsible for cellular senescence. Kondoh et al (2005) 
illustrated this by showing the link between senescence and the process of 
glycolysis. In their study, they demonstrated that an increase in glycolysis can 
bypass cellular senescence whereas, the inhibition of glycolysis results in 
premature senescence. By this they managed to show that indeed there is a link 
between oxidative stress and cellular senescence. This study was in agreement 
with studies done by Lee et al (1999) and Parrinello et al (2003) who proposed 
that the increase in ROS and oxidative stress have a part to play in the 
occurrence of senescence. Reports by Chen et al (1995; 2001) indicated that 
even mild oxidative stress such as low concentrations of hydrogen peroxide is 
enough to induce senescence. In summary, oxidative stress stimulates telomere-
independent senescence. The prevention of oxidative stress is therefore 
 
 
 
 
11 
 
expected to give answers to the question of the immortality of cancer cells. It has 
actually been suggested that the protection from oxidative stress can significantly 
increase life span (Kondoh et al, 2007). 
 
1.6 TOBACCO SMOKE AS SOURCE OF OXIDANTS 
The exposure to tobacco smoke stimulates the airway and parenchymal 
inflammatory cells to produce proteinases mainly elastase from neutrophils and 
different metalloproteinase from alveolar macrophages. This leads to an 
overwhelming of the antiproteinase defense in the epithelial lining fluid. Lung 
tissue studies show that different biological processes are involved in the 
pathogenesis of emphysema, such processes include imbalances between 
oxidant stress and antioxidant defenses in the lungs (MacNee, 2000; Tuder et al, 
2003) and between cellular apoptosis and regeneration (Aoshiba et al, 2003; 
Tuder et al, 2003). 
 
ROS found in cigarette smoke such as peroxynitrite and hydrogen peroxide have 
been shown to promote the phosphorylation and stimulation of extracellular 
signal–regulated kinases (ERK), p38, and c-jun N-terminal kinases (JNK). These 
mitogen-activated protein (MAP) kinases are known to have a significant effect 
on immune responses in the lung. The activation of Mitogen-activated protein 
kinase (MAPK) by ROS depends on the stimulation of particular tyrosine kinases 
such as the epidermal growth factor receptor (EGFR), which when stimulated 
undergoes homodimerization or heterodimerization consequently leading to the 
 
 
 
 
12 
 
autophosphorylation and activation of tyrosine kinase. Oxidants produced during 
cigarette smoke can rapidly inhibit the critical protein tyrosine phosphatases 
(PTPs) that provide an inhibitory constriction upon the system, thereby altering 
the signaling response to exogenous stimuli (Foronjy and D'Armiento, 2006). 
Oxidative stress generated by tobacco smoke may initially deplete glutathione, 
followed by a rebound increase of glutathione in chronic smoke exposure as an 
adaptive response to oxidative stress, which occurs as a result of the 
upregulation of y-glutamylcysteine synthetase (Rahman and MacNee, 1999).  
 
The most important defenses against oxidative stress are antioxidants; these 
include enzymatic and non-enzymatic antioxidants. The enzymatic antioxidants 
of the lung include glutamate, cysteine ligase, glutathione reductase, glutathione 
peroxidase, glucose-6-phosphate dehydrogenase, and in addition superoxide 
dismutases, catalase, heme oxygenase-1, peroxiredoxins, thioredoxins and 
glutaredoxins (Musellim et al, 2006; Chu et al, 2005). The non-enzymatic 
antioxidants are; glutathione, uric acid, alpha-tocopherol, bilirubin and lipoic acid, 
vitamins C and E, and beta-carotene (Rahman et al, 2004). These antioxidant 
defenses are found present in the lung epithelial lining fluids and within the lung 
cells (Arab et al, 2002) and are the first line of defense against the oxidants 
(Rahman et al, 2004). 
 
Fluids in the lining of the airways and extracellular spaces of healthy lungs are 
maintained in an extremely reduced state through millimolar levels of reduced 
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glutathione (GSH) to protect the normal physiologic functions of the lungs. 
Consequently, the levels of antioxidants and oxidants in healthy lungs are 
balanced in favor of a reducing state. An elevation in oxidants or a decrease in 
antioxidants can disrupt this equilibrium and thus result in oxidative stress. The 
presence of an imbalance in the oxidant–antioxidant system is one of the first 
events that result in inflammatory reactions in the lung (Musellim et al, 2006).  
 
The oxidant-antioxidant imbalance can result in the activation of cell surface 
receptors and inactivation of phosphatases, leading to the alteration of MAPK, 
NF-κB, and activator protein-1 (AP-1) signaling pathways, thus exacerbating 
inflammation (Foronjy and D’Armiento, 2006). Oxidative stress has been found to 
occur in many forms of lung disorders, such as pneumonia, acute respiratory 
distress syndrome (ARDS), idiopathic pulmonary disease, cystic fibrosis, 
bronchiectasis, ischemia–reperfusion injury, and lung cancer (Guo and Ward, 
2007). An altered oxidant– antioxidant balance has also been implicated in age-
related ocular diseases such as cataracts, age-related macular degeneration 
(AMD) and glaucoma (Yilmaz et al, 2005). 
 
1.7 CAROTENOIDS 
Carotenoids are common dietary constituents that are naturally contained in most 
fruits, including oranges or yellow and green vegetables. Carotenoids are known 
to exert antioxidant activities and prevent free radical-induced cellular damage 
(Bendich, 1993). Several researchers have investigated the potential role of 
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antioxidant nutrients in prevention of chronic diseases and aging processes in 
humans (Mayne, 2003). Evidence shows that the use of carotenoids is a 
prospective approach to protecting lung integrity and lung function. High 
concentrations of carotenoids, such as lycopene, together with other antioxidant 
vitamins including vitamin C and vitamin E in the lung epithelial lining and lining 
fluids in the lung may provide an additional level of protection against oxidative 
and ozone induced damage (Arab et al, 2002).  Lycopene however is an effective 
antioxidant abundantly contained in tomato juice (Di Mascio et al, 1989).  It has 
been utilized to test the hypothesis that oxidant-antioxidant imbalance could be 
important rather than inflammatory cell influx with increased burden of 
proteinases (Kasagi et al, 2006). 
 
1.7.1 Lycopene 
Lycopene, a bioactive carotenoid present in many fruits and vegetables is the 
major carotenoid in fresh tomatoes and tomato products (Takeoka et al, 2001; 
Kaplan et al, 1990). Lycopene has been shown to have many beneficial health 
effects (Giovannucci, 1999) and is considered to be the most effective biological 
carotenoid in quenching singlet oxygen (Di Mascio et al, 1989). Since tobacco 
smoke contains more than 1015 oxidant molecules (Church and Pryor, 1985), it 
has been suggested that dietary carotenoid intake may influence the 
development of tobacco smoke-induced emphysema (Kasagi et al, 2006). 
Previous literature has demonstrated that carotenoids have antioxidant 
properties and prevent cellular injury induced by free radicals (Bendich, 1993). 
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The prospective role of antioxidants in the prevention of chronic diseases and the 
aging process in humans has been investigated by researchers (Mayne, 2003). 
 
Lycopene has antioxidant properties that have motivated interest in the tomato as 
a food with potential anticancer properties (Giovannucci, 1999). Although β-
carotene had been effective against some chemically induced cancers, it was not 
effective against tumors in the respiratory tract (Obermueller-Jevic et al, 2002). 
Lycopene and β-carotene have been measured in lung tissue, which therefore 
adds to the possibility that carotenoids are a good defense mechanism against 
oxidative stress (Takeoka et al, 2001). An experiment done by Agarwal et al 
(2001) revealed that the intake of tomato products provided protection against 
oxidative damage to serum lipids, Low density lipoproteins (LDL) lipids, proteins 
and lymphocyte DNA. It was also noted from their study that lycopene 
supplementation causes a decrease in DNA damage which, as they suggested, 
might play a significant role in the lowering of cancer by decreasing the oxidation 
of proteins and DNA (Arab et al, 2002). It was also observed in their study that 
lycopene supplementation lowered serum LDL oxidation. This lowering of LDL 
oxidation might have an important role in the lowering of cardiovascular diseases 
as it is well known that oxidized LDL play a significant role in the formation of 
foam cell and arterial plague (Jialal and Devaraj, 1996; Parthasarathy, 1998). In 
addition to this, previous literature reveals that the increase in oxidized proteins 
has an important role to play in the development of chronic diseases and the 
process of aging. Because some proteins function as metabolic enzymes, their 
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oxidative damage may thus bring about a loss of this particular function (Hu, 
1994; Stadtman, 1992).  
 
1.8 TOBACCO SMOKING AND RESPIRATORY HEALTH 
It has been estimated that cigarette smoking has caused 1 billion deaths in the 
twenty-first century (Ginzel, 2001). Studies have documented that cigarette 
smoke contains about 4800 compounds, 60 of which are identified as animal 
and/or human carcinogens. These compounds contained in tobacco include 
benzene, lead, and chlorinated dioxins and furans. Other components contained 
in tobacco smoke such as hydrogen cyanide and arsenic have been identified as 
harmful to the cardiovascular system. On the other hand, other components 
including acrolein, arsenic toluene, and  phenol have been recognized to 
unfavorably affect the respiratory, reproductive and nervous systems (Fowles 
and Bates, 2000; International Agency for Research on Cancer, 2004). 
 
1.9 MATERNAL SMOKING 
Stein et al (1999) successfully demonstrated the association between smoking 
during pregnancy with an increase in the occurrence of respiratory tract 
diseases. Despite the evidence that maternal cigarette smoke during pregnancy 
is detrimental to the developing fetus (Schwartz et al, 1972), smoking still 
remains a widespread habit and accounts for a significant proportion of fetal 
morbidity and mortality through both a direct (fetal) and an indirect (placental) 
exposure (Salihu and Wilson, 2007). It is estimated that the exposure to maternal 
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tobacco or nicotine accounts for approximately 5 to 10% of all fetal and neonatal 
deaths (Proskocil et al, 2005). From previous work done on this subject, 
researchers have proposed that if smoking mothers were to give up the habit 
early during pregnancy, they should expect pregnancy results equal to those of 
nonsmoking mothers (Schwartz et al, 1972). However, it should be noted that 
smoking during early pregnancy can still cause unfavorable outcomes (Seller and 
Bnait, 1995). 
 
Maternal cigarette smoke or nicotine exposure produces adverse effects in the 
lungs of offspring, these include; intrauterine growth retardation, low birth weight, 
premature birth, reduced pulmonary function at birth, and a high occurrence of 
respiratory illnesses after birth ( Proskocil et al, 2005; Egger and Aubert, 2005; 
Sekhon et al, 2004). In rats, the prenatal exposure to cigarette smoke decreases 
the number of pre-alveolar saccules and increases their size; this is expected to 
reduce the number of attachment points on small airways (Sekhon et al, 2004). 
 
It is also well understood that cigarette smoke contains a high concentration of 
oxidant molecules that are thought to have an important role to play in the 
development of smoke-related lung diseases (Foronjy and D’Armiento, 2006). 
The presence of these free radicals results in DNA damage and increased 
inflammatory cells such as macrophages and neutrophils (De Paepe et al, 1999). 
These effects are likely to occur in human infants whose mothers smoke during 
pregnancy. More studies done on rat models revealed that cigarette smoke and 
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nicotine exposure during pregnancy and lactation can result in a reduced lung 
volume, number of saccules and septal crests, elastin fibers in fetal lungs, 
reduction in elastic tissue, increased number of lamellar bodies in the lungs of rat 
pups which result in emphysema-like changes (Sekhon et al, 2004). 
 
In addition to these perinatal outcomes, some epidemiologic studies have 
suggested that a number of diseases observed in the offspring later on in life 
may also be related to maternal smoking during pregnancy.  While some 
researchers have pointed out that maternal smoking during pregnancy increases 
the risk of certain forms of childhood cancers in the prenatally exposed offspring 
(Brooks et al, 2004; Filippini et al, 2000), other studies have linked maternal 
smoking with respiratory diseases such as asthma and atopy in the next 
generation (Raherison et al, 2007; Alati et al, 2006). In addition to this, more 
studies have linked prenatal smoke exposure with postnatal pathologies such as 
neurologic and behavioral disturbances (Lavezzi et al, 2005), obesity (Al Mamun 
et al, 2006), type 2 diabetes (Montgomery and Ekbom, 2002), and hypertension 
(Oken et al 2005; Ng and Zelikoff, 2007). 
 
1.10 NICOTINE 
Nicotine, a tertiary amine, (Buccafusco, 2004) is the main psychoactive 
component of tobacco smoke (Perkins et al, 1994) and is accountable for the 
habitual use of tobacco (Tutka et al, 2005). Nicotine functions biologically by 
binding to nicotinic acetylcholine receptors (nAChR) where it mimics the action of 
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acetylcholine. These receptors are members of the ligand-gated ion channels 
which are found in the brain. The nAChR are found to exist on neurons and on 
non-neuronal tissue such as muscles and immune cells (Gallowitsch-Puerta and 
Tracey, 2005). Normal lung cells and lung cancer cells have high affinity to 
nAChR (Pontieri et al, 1996; Maus et al, 1998). Literature suggests that the 
interaction of nicotine with nAChR on the surface of rodent epithelium found in 
the bronchioles promotes cell proliferation (Cattaneo et al, 1997).  
 
1.10.1 Nicotine metabolism 
Nicotine molecules have a low polarity and slight hydrophobicity which is caused 
by the existence of hydrophobic pyridine and pyrrolidine rings. This property is 
what makes it possible for nicotine to easily cross the blood–brain barrier and 
enter into the brain tissue (Oldendorf, 1974; Oldendorf et al, 1993; Spector and 
Goldberg, 1982) or, as shown in pregnant women, cross the placenta without 
restraint (Van Vunakis et al, 1974; Luck et al, 1982). The spread of nicotine in the 
organs is highly dependent upon its ability to bind to specific tissue. For example, 
the spleen, the liver, the lungs, and the brain have high affinity for nicotine, as 
opposed to adipose tissue which is shown to have a relatively low affinity to 
nicotine (Benowitz, 1986). About 5 to 10% of total elimination accounts for the 
renal excretion of unchanged nicotine. (Benowitz et al, 1983; Rosenberg et al, 
1980). The rest is then metabolized mainly in the liver and in lungs although to a 
slight extent (Jacob et al, 1988; Benowitz et al, 1991). 
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(Hydroxylation)      (Oxidation) 
 
 
 
 
Figure 1.10.1 The main metabolites of nicotine are cotinine and nicotine-N′-oxide. Cotinine is 
metabolized by hydroxylation to trans-3′-hydroxycotinine and 5′-hydroxycotinine, N-oxidation to 
cotinine N-1-oxide, and N-glucuronidation (Pogocki et al, 2007). 
 
The major metabolites of nicotine are cotinine and nicotine-N′-oxide (figure 
1.10.1). The formation of cotinine occurs in the liver. About 70 to 80% cotinine 
and its metabolites is responsible for nicotine metabolism in humans (Jacob et al, 
1988; Benowitz et al, 1991; Hukkanen et al, 2005). The initial metabolism of 
cotinine includes oxidation of position 5′ of the pyrrolidine ring, a process which is 
mediated by a cytochrome P450 to an unstable intermediate 5′-hydroxynicotine 
(Murphy, 1973 ). The next step involves the metabolism of iminium cation to 
cotinine by a cytoplasmic aldehyde oxidase (Hibberd and Gorrod, 1983). Cotinine 
itself is also extensively metabolized, with less than 20% excreted unchanged in 
the urine (Benowitz et al, 1983). Nicotine is metabolized to nicotine-glucuronide 
(figure 1.10.1) and several other minor metabolites as well (Jacob et al, 1988; 
Benowitz et al, 1991; Hukkanen et al, 2005). 
Nicotine 
Nicotine-N′-oxide  Cotinine 
5′-hydroxycotinine Trans-3′-hydroxycotinine 
N-glucuronidation Cotinine N-1-oxide 
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Nicotine has the ability to cross the placenta without restraint (Luck et al, 1985) 
and has been shown to occur in substantial amounts in the milk of smoking 
mothers (Luck and Nau, 1984). When maternally administered, nicotine is 
metabolized by the cell of the mother and n-oxide is taken to the developing 
fetus. It is therefore expected to interact with the developing fetus and the 
offspring of smoking mothers and/or mothers using nicotine replacement therapy 
(NRT) for smoking cessation (Maritz, 2008) resulting in the interference with 
normal fetal lung development (Maritz et al, 1993). The levels of nicotine that 
cross the placenta are sufficient to alter signaling by nicotinic receptors present in 
fetal lung (Conti-Fine et al, 2000). Some studies have suggested that nicotine 
and its metabolites can inhibit the apoptotic destruction of cells whose DNA has 
been damaged by genotoxic initiators of carcinogenesis. The continuous 
exposure to nicotine might lead to an altered phenotype of endothelial cells. This, 
therefore, brings forth a concern as to whether NRT might be a contributing 
factor to carcinogenesis, although it is advised that the resultant effects of 
persistent smoking are far worse than any short term exposure to nicotine (News 
and Views, 2007). Nicotine has been implicated as the potential factor that 
promotes the development of lung cancer (Chu et al, 2005). 
 
As has previously been demonstrated by Maritz and Dennis (1998), exposure to 
maternal nicotine suppresses alveolarization of lungs of the offspring, causing a 
reduction in internal surface area for gas exchange. In rats, the prenatal 
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exposure to cigarette smoke decreases the number of pre-alveolar saccules and 
increases their size; this is therefore expected to reduce the number of 
attachment points on small airways (Collins et al, 1985). In another study done 
by Sekhon et al (2004), it was shown that the administration of nicotine in animal 
models caused lung hypoplasia and reduced surface complexity. 
 
Considering the addictive nature of nicotine and that smoking is a problem that is 
not likely to go away in the near future, seeking ways to lessen the impact of 
smoking during pregnancy are important (Proskocil et al, 2005). Since some of 
the effects of smoking during pregnancy are mediated by nicotine which as 
previously mentioned crosses the placenta to interact with nicotinic receptors in 
the lung of the developing fetus (Luck et al, 1985). 
 
1.11 NICOTINE REPLACEMENT THERAPY (NRT) 
In view of the fact that nicotine is the addictive component of tobacco smoke 
(Ginzel et al, 2007); NRT has been documented as the most effective remedy for 
smoking cessation in non-pregnancy (Silagy et al, 2000). NRT is now advertised 
to a great extent as a therapy for smoking cessation (Ginzel et al, 2007) and has 
been presented by some researchers as a remedy even for pregnant mothers 
(Ruiz, 2006). 
 
In support of this, these researchers argue that smoking during pregnancy 
already exposes the fetus to large quantities of the toxic substances present in 
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tobacco smoke, in addition to the high levels of nicotine. The use of NRT during 
pregnancy in contrast, exposes the fetus to lower levels of nicotine as opposed to 
the levels present in tobacco smoke. This will thus result in the elimination of the 
exposure to all other toxic substances present in tobacco smoke (Ruiz, 2006). 
They further argue that the cardiovascular effects of nicotine from NRT are less 
than those observed from smoking and that the regular use of NRT generates 
lower plasma nicotine concentrations (Dempsey and Benowitz, 2001). 
 
In the presence of all these claims, we should not be ignorant of the adverse 
effects nicotine has on the developing fetus. Studies continue to demonstrate 
that nicotine causes damage to fetal lung, heart and nervous system 
(Kleinsasser et al, 2005; Argentin and Cicchetti, 2004). The unfavorable effects 
of nicotine on the lung have been shown by some researchers to persist even 
after the administration of nicotine has stopped (Ruiz, 2006). According to 
previous work done by Maritz and Windvogel (2005), the administration of 
nicotine during pregnancy and lactation has long term effects on the 
maintenance of lung integrity, the development of the respiratory system, 
susceptibility to lung diseases as well as a reduction in lung function (Maritz and 
Windvogel, 2005). Studies done on the lung tissue of the fetal and neonatal rats 
show that the maternal exposure to nicotine during gestation and lactation leads 
to a continuous inhibition of glycogenolysis and glycolysis (Maritz, 1987) which is 
a result of a reduction in the activity of phosphorylase in the developing fetal lung 
(Maritz, 1986). 
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It is suggested that, maternal exposure to nicotine during gestation and lactation 
results in an alteration to the ‘program’ that regulates the aging process of the 
developing lung. This will cause an alteration to the structure and function of the 
fetal lung making it to be more vulnerable to diseases (Maritz, 2008). As a 
consequence of the unfavorable effects nicotine has on the development of the 
fetus, some researchers have therefore proposed that the prescription of NRT is 
not advisable for pregnant or lactating mothers (Maritz, 2008; Ginzel et al, 2007). 
 
1.12 SENESCENCE AND AGING OF THE LUNG 
Senescence can be defined as a progressive deterioration of the structural and 
physiological function with age, leading to a decrease in productivity, increasing 
susceptibility to various diseases and death (Hasty and Vijg, 2004; Partridge and 
Mangel, 1999). This is a change that not only occurs at organ level but also at 
the tissue and cellular levels of the body. Additionally, some researchers have 
described aging to be a continuous process which is initiated at conception and 
continues till death (Balcombe and Sinclair, 2001). The word senescence is 
frequently used interchangeably with aging. Both senescence and aging are 
characterized by the progressive changes in the tissues or organs of the body. 
The increase in damage from exogenous and intrinsic mechanisms (Droge and 
Schipper, 2007) is a key factor in the association between aging and the 
development of chronic diseases of the brain and musculoskeletal or 
cardiovascular system (Karrasch et al, 2008). 
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1.12.1 Cellular senescence 
Cellular senescence is defined as a complete and irreversible loss of replicative 
capacity occurring in primary somatic cells (Hayflick and Moorhead, 1961). It is 
characterized by the progressive morphological and functional change such as 
the decrease in proliferative activity in cells (Collado and Serrano, 2005); 
telomere shortening; a distinct, flat, and enlarged cell morphology (Pauwels et al, 
2001); resistance to apoptosis (Murphy, 2000); altered production of 
inflammatory and growth mediators (Mannino et al, 2002); and an increase in 
senescence associated β-galactosidase (SA-gal) activity (Fishman, 2005). 
 
Cellular senescence can be induced by telomere-dependent or telomere-
independent mechanisms. Telomere-dependent mechanisms include the 
shortening of telomeres that, when it reaches a significant length, initiates DNA 
damage response and cell cycle arrest. Telomere shortening is the most 
important determinant of cellular aging (Hasty and Vijg, 2004). Telomere is 
defined as replicative DNA sequences that cap the ends of eukaryotic 
chromosomes (Blackburn, 1997). In order to prevent the activation of DNA 
damage signaling at the termini of the chromosome, telomere capping is 
required. It has been suggested that individuals are born with long telomeres and 
the decrease in telomere length results in aging (Nalapareddy et al, 2008), thus 
its main function is to cap chromosomes in order to prevent an activation of DNA 
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damage (Blackburn, 1997).  Telomere shortening restricts the lifetime of primary 
human cells to a limited number of cell divisions (Hayflick, 1965). 
 
1.12.2 Relationship between aging and chronic diseases 
The relationship between aging, malnutrition and emphysema has also been well 
documented by researchers (Karrasch et al, 2008). Although normally linked with 
chronological aging which is characterized by the passing of time from birth and 
beyond, biological aging can occur prematurely and includes a diversity of 
cellular, molecular and structural changes based on various mechanisms at 
cellular, tissue and organ level (Karrasch et al, 2008). The increase in β-
galactosidase activity is considered to arise from lysosomal β-galactosidase and 
reflect the increase in lysosomal biogenesis that naturally occurs during 
senescence (Campisi and d’Adda di Fagagna, 2007). The senescent cells can 
reach a permanent or irreversible quiescent state of G1 growth arrest in which 
they are resistant to mitogenic and various apoptotic stimuli (Swanson et al, 
2009). 
 
1.12.3 The mechanisms of cellular senescence 
The major molecular and cellular mechanisms that have been linked with cellular 
aging include telomere attrition, cumulative DNA damage, the impairment of DNA 
repair, the epimutations in nuclear DNA, mutations in mitochondria, an increase 
in the rigidity of cytoskeleton, the increased cross-linking of the extracellular 
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matrix, protein damage, an increased production of free radicals, and the 
accumulation of waste products (Karrasch et al, 2008).  
 
Researchers have proposed that the accumulation of DNA damage is a 
contributing factor to aging (Lieber and Karanjawala, 2004). Free radicals that 
target G-triplets can also directly damage telomeres (Midorikawa et al, 2002), 
thus inducing single strand breaks (Chen et al, 2001). Aging induced by external 
factors such as oxidative stress, can result in the reduction of telomere length. A 
study done by Müller et al (2006) demonstrated that cultured parenchyma lung 
fibroblasts from patients with emphysema did not show any alterations in 
telomere length although there were obvious signs of cellular senescence. This, 
therefore, indicates that telomere shortening could not have been the cause of 
senescence in this case, suggesting that alternative mechanisms could have 
been active in these cells (Müller et al, 2006). 
 
Telomere-independent premature senescence on the other hand, is induced by 
mechanisms that initiate the development of ROS. The ROS can induce DNA 
damage, or alter chromatin structure. Senescence can also be induced by certain 
cell culture conditions, overexpression of oncogenes and the presence of anti-
proliferative cytokines, in particular TGF-β (Campisi and d’Adda di Fagagna, 
2007). There are various mechanisms that can stimulate DNA damage. These 
include replication errors, telomere shortening and the degeneration of ROS, 
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toxic metabolites, irradiation, ultraviolet radiations and exposure to environmental 
toxins (Vijg, 2008).  
 
1.12.4 Relationship between smoking and senescence 
Smokers show signs of premature aging (Kadunce et al, 1991; Tanaka at al, 
2007; Yin et al, 2001). It has been proposed that the development of emphysema 
in COPD involves inflammation induced by cigarette smoke and leukocyte 
activation (fig 1.13), as well as the imbalances between oxidant-antioxidant and 
protease-antiprotease (Karrasch et al, 2008). Cigarette smoking is the most 
important risk factor for pulmonary emphysema and fibrosis. It is actually 
considered to be the cause of persistent epithelial injury and impaired repair. 
Some studies have demonstrated that cigarette smoke results in the death of 
alveolar epithelial cells (Lannan et al, 1994), and that it also hinders epithelial 
repair responses, such as chemotaxis, proliferation, and contraction of three-
dimensional collagen gels (Wang et al, 2001). 
The main physiological alterations that occur in the senile respiratory system may 
indicate mechanical or structural changes, most particularly reduced lung 
elasticity, an increase in stiffness of the chest wall, and reduced respiratory 
muscle strength (Dyer and Stockley, 2006).   
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Figure 1.13.4 Diagram illustrating a summary of the key aspects of aging and senescence that 
are involved in the development of lung emphysema (Karrasch et al, 2008). 
 
Furthermore, there is a slight loss in the actual number of small airways 
(Thurlbeck, 1992); the distance between airspace walls is increased, whereas 
the internal surface area of the lung is decreased (Pierce et al, 1961). This is a 
result of larger pores that exist in the aged alveoli. There is also evidence of 
alveolar septal thickening with age and the alveoli becomes shallower (Verbeken 
et al, 1992).The human lung exhibits a number of functional and structural 
changes that are part of the normal aging process (Janssens et al, 1999; Sprung 
et al, 2003). These changes include the rarification of alveolar structures which is 
known to occur in older never-smokers (Pinkerton and Green, 2004). Although 
the structural alterations of the senile lung are considered to be nondestructive 
Stress induced premature senescence 
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(Janssens et al, 1999), and are rather homogeneous when compared with the 
more focal alterations in emphysema (Verbeken et al, 1992), the overall result 
appears to be similar with regard to the loss of tissue renewal and regenerative 
potential (Karrasch et al, 2008). 
 
Evidence from previous studies indicates that smokers show signs of premature 
aging which is particularly evident in the skin. The link between aging and chronic 
disease is well-known (Karrasch et al, 2008). Oxidative stress is closely 
associated with the protease-antiprotease imbalance; it originates from 
compounds of cigarette smoke or inflammatory cells and has the capability to 
overcharge the antioxidative capacity of pulmonary tissue and further decrease 
the antiprotease defense (Wright and Churg, 2007). 
 
The epithelium of the alveoli is frequently injured by a number of inhaled toxins, 
such as sulfur dioxide, ozone, nitrogen dioxide, and cigarette smoke, leading to 
the initiation of repair responses. These toxins also induce oxidative stress and 
DNA damage in epithelial cells consequently leading to stress-induced 
senescence. As soon as the epithelial cells reach the stage of senescence, they 
are no longer able to proliferate, leading to the cessation of the repair responses 
by alveolar epithelial cells. This cessation consequently, results in the disruption 
in the architectural integrity of the alveoli thus; the lung becomes more 
susceptible to diseases (Tsuji et al, 2004). The repair responses by alveolar 
epithelial cells require their integrated ability to migrate, proliferate, and 
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differentiate to cover defects that result from the injury (Rennard, 1999).  It has 
been proposed that the inability of the epithelium to repair itself is an important 
cause of chronic lung diseases, such as pulmonary emphysema and fibrosis 
(Yokohori et al, 2004). 
 
Several markers associated with telomere independent senescence have been 
identified, some of these include, thymidine labeling index, which monitors the 
number of replicating cells in the population under specific conditions which is 
related in a log/linear relationship to replicative life span and BrdU labeling and 
colony size distribution. Other markers such as lipofuscin deposition and 
lysosomal enzyme activity have also been proposed. SA-β-Gal measured at pH 
6.0 selectively stains senescent cells.  The pH 6.0 activity (also known as 
Senescence-associated β-galactosidase) is widely used to identify the presences 
of senescent cells in vitro. This method is not only easy, but also rapid and 
convenient to use (Cristofalo, 2005). 
 
1.13 MOTIVATION OF THE STUDY 
Several studies showed that maternal nicotine exposure results in the late onset 
of gradual parenchymal deterioration (Maritz, 1996; Maritz et al 1993; Müller et 
al, 2006; Verbeken et al, 1992). It is suggested that this is due to a change in the 
“program” that controls lung aging (Maritz, 2008). It is hypothesized that this 
change is brought about by an imbalance in the oxidant-antioxidant capacity of 
the lungs during fetal and neonatal development. Thus, the overall aim of this 
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study is to restore the oxidant-antioxidant capacity of the developing lungs by 
allowing the mothers to consume tomato juice and thus lycopene. 
 
1.14 AIMS AND OBJECTIVES 
The main objectives of this study are therefore: 
• Firstly, to determine effects of maternal nicotine exposure during gestation 
and lactation on lung development in the offspring. 
• Secondly, to establish whether tomato juice can have protective effects on 
the fetal lung development and function in the offspring. 
• Thirdly, to determine if apoptosis is the cause of the thickening of the 
alveolar wall that is observed as the offspring increases in age or the 
development of emphysema. 
• To determine whether tomato juice supplementation will prevent 
premature aging of the lungs of rats that was exposed to nicotine via the 
placenta and mother’s milk. 
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CHAPTER 2 
Materials and Methods 
2.1 ANIMAL PREPARATION 
White Wistar female rats were used in this study. The animals were mated for a 
period of seven days. During the seven days mating period, the rats all received 
water and the normal laboratory chow. The breeding program was maintained in 
the animal house of the Department of Medical Bio-Sciences at the University of 
the Western Cape. The room temperature was maintained at 22 ± 1°C, with day-
night cycle of 12 hours. After the seven days mating was complete, the pregnant 
animals were weighed in order to determine the initial body weight. The animals 
were then randomly assigned to four different groups (with at least 6 animals per 
group) as follows; 
 
• The first group was the control which received saline only. 
• The second group received nicotine only. 
• The third group received both nicotine and tomato juice. 
• The fourth group received tomato juice. 
 
The treatment of all four groups began as soon as the mating period was ended 
and was terminated at weaning when the offspring born to these mothers were 
21 days old. It is important to note that the offspring were not treated with 
nicotine, saline or tomato juice. Since nicotine crosses the placenta and occurs in 
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the milk of smoking mothers (Luck and Nau, 1984), the offspring would therefore 
be exposed to nicotine only via the placenta and the mother’s milk. 
 
2.1.1 Ethical Clearance  
The approval for the use of rats as experimental animals and the ethical 
clearance for the study were obtained from the Ethical Committee of the 
University of the Western Cape. 
 
2.1.2 Nicotine Administration 
The administration of nicotine to the mothers began as soon as the mating period 
was over.  The nicotine was administered subcutaneously using sterile 1ml 
tuberculin syringes. The dose of nicotine and saline was 1mg/kg of the initial 
maternal body weight. This dose remained constant throughout the entire 
experiment. The nicotine solution was prepared by diluting 1mg nicotine with 
100ml of distilled water. The nicotine solution was prepared weekly. All the 
animals were treated once a day between 08h30 and 09h30.  Much care was 
taken when treating the animals in order to prevent any stress that could be 
caused during the process. The group that received tomato juice only was 
administered with neither nicotine nor saline. After the completion of the mating 
period, the administration of nicotine, saline and tomato juice to the experimental 
and control groups continued till weaning on postnatal day 21. 
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2.1.3 Administration of Tomato Juice 
As part of the experiment, tomato juice was freely available to drink by the 
animals that received a tomato juice supplementation. The tomato juice for these 
groups replaced their water intake. The brand of tomato juice that was used was 
the All Gold Tomato juice (containing 9mg of lycopene per 100ml). The tomato 
juice (lycopene) was prepared using a 50% dilution with tap water (to reduce its 
density) and given to the rats in water bottles. The control animals and the group 
treated with nicotine only received water. The total volume of liquid intake for the 
groups that received tomato juice and that of those that received water was 
measured per day for each rat. The liquid intake of the two groups was later 
compared to determine the total liquid intake for each group. 
 
The mothers were all weighed weekly to determine if there were any changes in 
body weight within the different groups. The animals were all fed with the normal 
laboratory rat chow throughout the experiment. 
 
2.2 LUNG EXTRACTION 
The lungs were extracted from weaned pups at four different age groups namely 
postnatal days 21, 42, 63 and 84. Lungs from least 3 pups from each litter were 
used and at least 4 litters from each of the four age groups. The rat lungs were 
fixed in 10% buffered formaldehyde solution after the removal from the thorax. 
The following reagents were used to make up 10% buffered formaldehyde 
solution: 
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• Formaldehyde      100ml  
• Distilled water      900ml 
• Sodium phosphate  (anhydrous)   4g  
• Sodium phosphate  (dehydrogenous)  6g  
 
Before the rats were sacrificed, they were weighed and the weight was recorded. 
The chest circumference and the crown-rump length were subsequently 
measured and recorded. The pups were sacrifices by injecting them with an 
overdose of approximately 0.5ml per kg BW of sodium pentobarbitone solution. 
When the rat was completely unconscious, the thoracic cavity was carefully 
opened. Special care was taken to prevent damage to the lungs. Lungs that were 
damaged during the dissection were discarded. The fixative was allowed to flow 
freely into the lungs at a transpulmonary pressure of 25cm water. When the flow 
stopped, the lungs were kept in the thorax at this pressure for 10 minutes before 
it was removed. The trachea was closed before removal by tube by binding it 
with a string that was then tightly placed around the trachea to prevent any 
leakage of liquid from the opening made in the trachea. 10% neutral buffered 
formaldehyde was used to inflate the lungs whilst still in the ribcage. The ribcage 
acts as a protective mechanism from over expansion of the lung that could lead 
to breaking of the lung tissue. Inflating the lungs in the ribcage assists in keeping 
the natural environment of the thoracic cavity to ensure that the inflation is 
proportional to the maximum air volume the lung can naturally hold. After the 
lungs were fully inflated, the intra-tracheal installation tube was removed and the 
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string was then tied tightly around the trachea to ensure that the liquid does not 
leak out. Following that, the lungs were rapidly and delicately extracted from the 
ribcage, the heart and trachea were removed.   
 
The lung volume was then determined using the fluid displacement technique of 
Scherle (1970). The lungs were afterward placed in 10% buffered formalin where 
they kept for a maximum time of a week before further processing. 
 
2.3 PROCESSING AND EMBEDDING OF THE LUNG TISSUE 
An automatic tissue processor was used. The lungs were delicately handled at 
the trachea to avoid any damage that could be caused to the lung tissue and 
placed on a clean glass tile. For each lung, the left lobe was cut off gently using a 
scalpel, and perfectly placed in a properly labeled cassette. When all the 
cassettes containing the lung tissue were ready, they were placed into the tissue 
processing rack of the automatic tissue processor. The processor was 
programmed so that the lungs to be processed followed an 18 hour cycle as 
follows; 
• Firstly, in ascending graded ethanol solutions (70%, 80% and 90%) for 
two hours in each solution. 
• Then, for 2 hours in 100% ethanol (repeated once for a total of 4 hours in 
100% ethanol solution). 
• Followed by 2 hours in 100% xylene (repeated once for a total of 4 hours 
in 100% xylene solution). 
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• Lastly, for 2 hours in wax (repeated once for a total of 4 hours in wax). 
 
After the 18 hour cycle was complete, the cassettes were removed from the 
tissue processing rack. A small amount of wax was left to run into a mould to 
ensure that it covered the base of the mould smoothly. The lobe was then 
removed from the cassette and placed onto the mould with the lateral surface 
facing downwards. More wax was then let to run onto the mould ensuring that the 
tissue sample was fully covered with wax. The mould was afterward placed on a 
laboratory freezer for about 10 minutes so as to solidify the wax to facilitate in the 
sectioning. 
 
2.4 MICROSCOPY AND SLIDE PREPARATION 
When the wax had solidified, the cassettes were removed from the mould. The 
access wax was then removed from the cassettes using a dissecting knife. A 
microtome was used to cut the tissue into sections. The bevel angle used was 6o 
and a 5µm sections were obtained for the study. 
 
The cut sections were carefully placed in a water bath (heated to 45 o C) in order 
to flatten them. The sections were then picked up using clean microscope slides 
and left over night to be fixed on to the slide.  Following this, the slides were 
placed on a staining rack and then put in a hot air oven at 80 o C for 
approximately 5 minutes to further fix the tissue and to melt the wax. 
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2.5 STAINING 
2.5.1 H and E staining 
• The tissue sections (attached to microscope slides) were immersed in 
fresh xylene for 5 minutes and repeated once for a total of two xylene 
washes (that is 10 minutes). 
• Slides containing the tissue sections were then dehydrated using absolute 
alcohol for 5 minutes in 100% ethanol solution and repeated once for a 
total of 10 minutes in 100% ethanol. 
• This process was continued by repeating the procedure described above 
in 90% and then 80% ethanol for 5 minutes each. The slides were rinsed 
well in running tap water. 
• Staining was subsequently done in Haematoxylin for about 15 minutes 
and then rinsed in running tap water. 
• Next, the slides were blued in Scott’s tap water for 2 minutes then rinsed 
under tap water and differentiated in 1% acid alcohol, and rinsed under 
tap water again. 
• Following that, a counter stain in Eosin was done for 3 minute done, after 
which the slides were rinsed again in running tap water to rinse excess 
stain. 
• The slides were then placed in 80% and 90% ethanol solutions for 2 
minutes each and then placed in xylene for another 2 minutes and then 
left to dry for about 30 minutes  
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• The slides were mounted then allowed to dry for morphometric and 
morphologic analysis. 
 
2.5.2 Staining for Apoptosis 
2.5.2.1 Principle 
In the present study, the DeadEnd™ Fluorometric TUNEL kit which evaluates 
apoptotic cell death in systems such as cultured cells or paraffin-embedded 
tissue sections was used for detection of apoptosis. This System may be used 
for the determination of nuclear DNA fragmentation, which is an important 
biochemical characteristic of apoptosis in many cell types. It determines 
fragmented DNA of apoptotic cells by catalytically incorporating fluorescein-12-
dUTP at 3´-OH DNA ends using the Terminal Deoxynucleotidyl Transferase, 
Recombinant, enzyme (rTdT). rTdT forms a polymeric tail using the principle of 
the TUNEL. The fluorescein-12-dUTPlabeled DNA may be observed by using 
fluorescence microscopy. Samples are analyzed under a fluorescence 
microscope a standard fluorescein filter set can be used to observed green 
fluorescence of fluorescein at 520 ± 20nm. 
 
2.5.2.2 Method  
• Tissue sections were immersed in fresh xylene for 5 minutes at room 
temperature. This was repeated once for a total of two xylene washes. 
• The samples were then washed by immersing the slides in 100% ethanol 
for 5 minutes at room temperature. 
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• Next, the samples were rehydrated by sequentially immersing the slides 
through graded ethanol washes (100%, 95%, 85%, 70%, and 50%) for 3 
minutes each at room temperature. 
• Samples were then washed by immersing the slides in 0.85% NaCl for 5 
minutes and then immersed in PBS for 5 minutes at room temperature. 
• The samples were subsequently fixed by immersing the slides in 4% 
methanol-free formaldehyde solution in PBS for 15 minutes at room 
temperature and afterwards washed using in PBS for 5 minutes at room 
temperature. This step was then repeated once for a total of two PBS 
washes. 
• The excess liquid was removed from the tissue using a paper towel and 
the slides were placed on a flat surface and 100µl of 20µg/ml Proteinase K 
was added to each slide to cover the tissue section. Slides were afterward 
incubated for 8–10 minutes at room temperature. 
• Samples were again washed by immersing the slides in PBS for 5 minutes 
at room temperature and fixed in 4% methanol-free formaldehyde solution 
in PBS for 5 minutes at room temperature. 
• A final wash was then done by immersing the slides in PBS for 5 minutes 
at room temperature. 
• The excess liquid was removed by tapping the slides, the tissue samples 
were then covered with 100µl of equilibration buffer. The slides were left to 
equilibrate at room temperature for about 5–10 minutes. 
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• While the tissue samples were equilibrating, the Nucleotide Mix was 
thawed on ice and a sufficient rTdT incubation buffer for all samples was 
prepared. 
• The area around the equilibrated surface was then blotted with tissue 
paper to remove most of the 100µl of Equilibration Buffer and 50µl of rTdT 
incubation buffer was subsequently added to the tissue samples on a 5 
cm2 area and exposure of slides. Light was avoided from this step onward. 
• Tissue samples were covered with Plastic cover slips to ensure the even 
distribution of the reagent. Paper towels soaked with water then placed at 
the bottom of a humidified chamber. The slides were incubated for 60 
minutes at 37°C inside the humidified chamber to permit the tailing 
reaction to occur. The chamber was covered with aluminum foil to protect 
it from direct light. 
• A 20X SSC 1:10 dilution was made with distilled water and a sufficient 
amount of the resulting 2X SSC. The plastic cover slips were removed at 
this stage. 
• The reaction was then stopped the by immersing the slides in the 2X SSC 
in a Coplin jar for 15 minutes at room temperature. 
• The samples were washed again by immersing the slides in fresh PBS for 
5 minutes at room temperature. 
• The samples were then stained using DAPI solution freshly diluted to 1ml: 
10ml in PBS for 5 minutes at room temperature in the dark.  
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• Following this, a final wash was done in PBS for 5 minutes. This was 
repeated two times for a total of 3 washes in PBS. 
• The excess water was subsequently drained off from the slides and the 
area surrounding the tissue samples was wiped with tissue paper. 
Samples were analyzed immediately under a fluorescence microscope to 
view the green fluorescence of fluorescein. 
 
2.6 MORPHOMETRIC TECHNIQUES 
The morphometric techniques used in this study included:  
• Volume Density (Va and Vt) 
• Mean Linear intercept (Lm)  
• Alveolar wall thickness (Tsept) 
• Lung Volume (Lv) 
 
2.6.1 Volume Density (Va and Vt)  
2.6.1.1 Principal 
Alveolar volume gives an indication of the size of the alveolus and thus the 
volume of air that occupies it. It is expected that in alveoli with larger volumes, 
the total surface area for gaseous exchange in the lung would be reduced. This 
also would indicate that there would be a possibility of less alveolar surface area 
for gaseous exchange and less alveoli. According to Blanco et al (1991), the 
average size of an individual alveolus increases with age. 
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2.6.1.2 Method 
The alveolar air volume density (Va) and alveolar tissue volume density (Vt) were 
determined as illustrated by Bolender et al (1993). A 122-point eyepiece graticule 
was used at 100 x magnifications for the point counting technique which helped 
in determining the alveolar air volume density Va and Vt. 
 
A 10x eyepiece and a 10x objective were used to obtain a total magnification of 
100x. Two blocks were taken from the upper lung lobe, 1 from the middle lobe 
and two from the lower lobe. Non-parenchyma tissue included bronchus and 
blood vessels which had a diameter of >1.1mm. The alveoli that were found 
within the graticule and those that touched the lower and right borders of the 
graticule were included. The alveoli were excluded from the count including those 
that were outside the square on the upper and the left side of the graticule. 
Furthermore, the fields surround by non-parenchymatous tissue were excluded 
from the counts. At least 5 randomly selected non-overlapping fields were 
analysed for each slide. 
 
The alveoli that contributed to the count included:  
• Those that were found within the graticule, and  
• Those that touched the right lower borders of the graticule.  
 
The alveoli that did not contribute in the count included:  
• Those found outside the square on the upper left side of the graticule.  
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• Areas that contained non-parenchymatous tissue were excluded from the 
counts. At least 5 randomly selected non-overlapping fields per slide were 
analysed. 
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The following method was used to calculate the number count (Na):  
 
Example: 
1          2        3        4        5         6         7         8        9       10       11 
                    
  
 
         
  
        
  
  
        
  
  
        
  
  
        
  
  
        
  
  
        
  
                    
 
5 points on the lines 
Total lines/points = 110 
Therefore, 5/110 X 100 = 4.55% 
 
2.6.2 Determination of Mean Linear Intercept (Lm) 
2.6.2.1 Principle 
The Mean linear intercept (Lm), is the average distance found between alveolar 
walls and indicates the diameter of the alveolus (Dunnill, 1962). During normal 
lung maturation, the Lm increases with decreasing air-tissue interface. In 
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microscopic emphysema however, the Lm has been observed to increase, 
indicating alveolar wall destruction and an increase in alveolar volume. Increase 
in Lm is indicative of a decrease in surface area available for gaseous exchange. 
 
2.6.2.2 Method 
The linear intercept was calculated as follows; 
Lm = L x L/m 
Where  
N = number of fields counted 
L = length of cross line (0.02 mm at 100x magnification) 
M = sum of all intercepts 
 
An intercept is where the cross line passes through the alveolar wall. Crossing an 
alveolar wall = 2 intercepts. The line just touches an alveolar wall = 1 intercept. 
The number of alveolar intercepts (m) was determined using an eyepiece 
micrometer at 100x magnification. For each slide 5 fields were used to determine 
the mean linear intercept. 
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Example: 
Field  # of intercepts  
1   26 
2   16 
3   22 
4   25 
5   15 
  Total: 104 
 
Lm = 2.02 x 5/104 
      = 10.1/104 
      = 0.097mm 
      = 97µM 
 
The following alveolar walls contributed to the intercept count:  
• Those that touched without crossing the left side of the vertical line,  
• Those that touched without crossing the upper end of the horizontal line, 
and  
• Those that intercepted the cross hairs.  
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Cut blood vessels were each counted as half an intercept.  
 
Structures and Alveolar walls that did not contribute to the mean linear intercept 
included:  
• Those that touched but not cross the right border of the vertical arm, and  
• Those that touched but not cross the lower border of the horizontal arm. 
 
2.6.3 Alveolar wall thickness (Tsept)  
2.6.3.1 Principal 
The Alveolar wall thickness (Tsept) is the distance between alveoli that are 
adjacent to each other or the thickness of the wall of the alveoli between adjacent 
alveoli. Tsept is determined by utilizing the point counting and linear intercept 
method as described by Weibel (1963). The Weibel no. 1 graticule at 100x 
magnification was used to determine the number of points on the alveolar 
septum and number of alveolar intercepts. At least 5 non-overlapping fields that 
were randomly selected were analysed for each slide. 
 
2.6.3.2 Method 
The calculation of the Tsept was done using the following equation:  
Tsept = z x Pse/2x Ise,  
Where:  
z = lengths of lines on graticule (um)  
Pse = points on alveolar walls  
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Ise = number of intercepts of alveolar walls  
 
2.6.4 Statistical Analysis (Morphometry)  
The results were analysed on the Microsoft Excel data analysis programme using 
standard error bars and a one-way analysis of variance test (ANOVA) for 
unpaired data and the Student t-test for pair-wise comparisons. A probability 
level of P<0.05 was chosen as significant to the study and the values were 
recorded as means ± standard error of means.  
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CHAPTER 3 
Results 
3.1 THE EFFECTS OF MATERNAL NICOTINE AND TOMATO JUICE ON 
THE BODY WEIGHT (BW) OF THE OFFSPRING. 
From the data summarized in table 3.1 and illustrated in figure 3.1, it is clear that 
up to postnatal day 42 the body weight (BW) of the males and females were the 
same (P > 0.05).  However, from postnatal day 42 the BW of the males increased 
faster (P < 0.05) than that of the females so that on postnatal days 63 and 84, the 
BW of the males was higher (P < 0.05) than that of the females.  
 
The exposure of the mothers during gestation and lactation to tomato juice, 
nicotine, or to both nicotine and tomato juice had no effect on the BW the males 
or females (P > 0.05). 
 
3.2 THE EFFECTS OF MATERNAL NICOTINE AND TOMATO JUICE ON 
CC/BW AND CC/CR OF THE OFFSPRING. 
From postnatal day 21 to postnatal day 84, the chest circumference (CC) of the 
control and experimental male animals increased between 1.65 and 1.94-fold; 
the CC of the female control animals increased between 1.42 and 1.71-fold. By 
postnatal day 84, the CC of the males within all the groups was higher (P<0.01) 
than that of the females. There was no difference (P>0.05) between the CC of 
the control animals and that of the experimental groups at postnatal day 84. 
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From table 3.2 and figures 3.2 it is clearly indicated that no differences (P > 0.2) 
in the CC/BW ratios were observed between the control and the nicotine group 
on postnatal day 21. However, the CC/BW ratios of the control animals were 
lower than that of the animals that were exposed to tomato juice and those 
exposed to both nicotine and tomato juice. At postnatal day 84, there were no 
differences observed (P>0.05) in the CC/BW ratios of the control male animals 
and the male experimental animals. Similarly, there were no differences between 
the CC/BW ratios of the control female animals and that of the female 
experimental groups of the same age. At postnatal days 63 and 84, the CC/BW 
ratios of the female animals of each group was significantly higher (P<0.01) than 
that of the males. Within the tomato group, the CC/BW ratios of the male animals 
were 32% higher (P>0.001) than that of the female animals. On postnatal day 84, 
no differences (P>0.05) were observed between the control and the experimental 
animals. 
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Table 3.1 The effects of maternal exposure to nicotine, tomato juice, or both nicotine and tomato 
juice on the body weight (g) of the male and the females offspring at postnatal days 21, 42, 63, 
and 84. P-value: No differences within experimental groups up to day 42 (P > 0.05). Postnatal 
day 63 Males vs. Females (P < 0.05). Postnatal day 84 Males vs. Females (P < 0.05). 
Age 
(days) Sex Control  
C vs. 
N Tomato C vs. T Nicotine C vs. N+T N+T 
21 
Males 40.36±0.88 P>0.05 36.84±1.22 P>0.05 44.77±1.27 P>0.05 36.43±1.56 
Females 40.36±0.88 P>0.05 36.84±1.22 P>0.05 44.77±1.27 P>0.05 36.43±1.56 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 
Males 140.21±7.07 P>0.3 121.98±3.67 P<0.04 131.30±5.59 P>0.9 141.00±5.58 
Females 130.14±2.79 P>0.4 111.85±3.88 P<0.001 135.43±7.11 P>0.1 122.70±3.57 
M vs. F 
 P>0.1  P>0.8  P>0.6  P>0.1 
63 Males 269.33±5.59 P>0.5 245.61±6.97 P<0.02 262.51±11.35 P<0.04 248.94±4.49 Females 210.14±9.61 P>0.6 184.77±5.05 P<0.03 216.41±7.46 P>0.06 186.61±5.70 
M vs. F 
 P<0.001  P<0.001  P<0.002  P<0.001 
84 Males 330.43±2.40 P>0.6 339.49±7.66 P>0.2 338.25±15.16 P>0.6 325.03±12.26 
Females 237.26±6.30 P>0.9 229.98±6.92 P>0.4 231.19±10.70 P>0.9 230.07±4.31 
M vs. F 
 P<0.002  P<0.001  P<0.001  P<0.001 
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Figure 3.1 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the body weight of the male and female offspring at postnatal days 21, 42, 63, 
and 84. 
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Table 3.3 and figure 3.3 indicate that no significant differences (P > 0.05) in the 
CC/CR ratios were seen when the control was compared to the experimental 
animals on postnatal day 21. On postnatal day 84, the CC/CR ratios of the 
female control animals was slightly but significantly lower (P<0.04) than that of 
the female N+T group. However, there were no differences observed when the 
CC/CR ratios of the control male and female animals were compared to that of 
the males and females that were exposed to tomato juice and those that were 
exposed to both tomato juice and nicotine on postnatal day 84. However, the 
CC/CR ratios of male nicotine group was significantly higher (P<0.009) than that 
of the female nicotine groups at postnatal day 84. 
 
Although the data in tables 3.2 and 3.3 indicate that the CC/BW ratios of male 
animals increased faster than that of the female animals, the CC/BW and the 
CC/CR ratios were not affected by the maternal exposure to tomato juice, 
nicotine, or to both nicotine and tomato juice (P>0.05) during gestation and 
lactation. It also means that growth was proportional for the control as well as the 
experimental animals. 
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Table 3.2 The effect of maternal exposure to nicotine, tomato juice, and both nicotine and tomato 
juice on the CC/BW ratio of the male and female offspring at postnatal days 21, 42, 63, and 84. 
P-value: No significant difference within experimental groups and within age groups from day 21 
to day 84 (P>0.05). 
Age 
(days) Sex Control  
C vs. 
N Tomato C vs. T Nicotine 
C vs. 
N+T N+T 
21 
Males 20.43±0.43 P>0.2 22.62±0.72 P<0.01 19.64±0.48 P<0.003 23.00±0.76 
Females 20.43±0.43 P>0.2 22.62±0.72 P<0.01 19.64±0.48 P<0.003 23.00±0.76 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 
Males 8.62±0.33 P>0.2 9.53±0.29 P>0.05 9.19±0.31 P>0.5 8.30±0.34 
Females 8.76±0.22 P>0.2 9.73±0.17 P<0.01 9.23±0.40 P>0.06 9.38±0.21 
M vs. F 
 P>0.7  P>0.6  P>0.9  P<0.01 
63 
Males 5.57±0.10 P>0.8 5.85±0.18 P>0.2 5.50±0.30 P>0.2 5.79±0.16 
Females 6.30±0.23 P>0.9 7.09±0.21 P<0.01 6.26±0.24 P<0.03 7.04±0.21 
M vs. F 
 P<0.01  P<0.001  P>0.06  P<0.003 
84 
Males 4.80±0.09 P>0.6 4.64±0.12 P>0.3 4.90±0.24 P>0.8 4.78±0.12 
Females 6.10±0.18 P>0.8 6.12±0.16 P>0.9 6.14±0.20 P>0.5 6.22±0.13 
M vs. F 
 P<0.001  P<0.001  P<0.003  P<0.001 
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Figure 3.2 The effect of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice during gestation and lactation on the CC/BW ratio at postnatal days 21, 42, 63, and 
84. 
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Table 3.3 The effects of maternal exposure to nicotine, tomato juice and the combination of both 
nicotine and tomato juice on CC/CR ratio at postnatal days 21, 42, 63, and 84. P-value: No 
significant difference within experimental groups and within age groups from day 21 to day 84 
(P>0.05). 
Age 
(days) Sex Control  C vs. N Tomato C vs. T Nicotine 
C vs. 
N+T N+T 
21 
Males 8.93±0.07 P>0.2 9.03±0.11 P>0.4 8.78±0.12 P>0.9 8.93±0.09 
Females 8.93±0.07 P>0.2 9.03±0.11 P>0.4 8.78±0.12 P>0.9 8.93±0.09 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 
Males 8.19±0.13 P>0.8 8.10±0.13 P>0.6 8.24±0.19 P>0.08 7.88±0.11 
Females 7.84±0.11 P<0.01 7.88±0.11 P>0.8 8.41±0.19 P>0.05 8.22±0.14 
M vs. F 
 P>0.05  P>0.2  P>0.5  P>0.06 
63 
Males 7.90±0.13 P>0.05 7.52±0.10 P<0.03 7.53±0.11 P>0.3 7.70±0.20 
Females 7.42±0.13 P>0.7 7.42±0.11 P>0.9 7.47±0.12 P>0.5 7.52±0.08 
M vs. F 
 P<0.01  P>0.5  P>0.7  P>0.3 
84 
Males 7.84±0.17 P>0.2 7.74±0.15 P>0.7 8.09±0.11 P>0.5 7.69±0.17 
Females 7.54±0.17 P>0.9 7.84±0.13 P>0.2 7.53±0.14 P<0.04 8.01±0.11 
M vs. F 
 P>0.2  P>0.6  P<0.009  P>0.1 
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Figure 3.3 The effect of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice during gestation and lactation on the CC/CR ratio at postnatal days 21, 42, 63, and 
84. 
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3.3 THE EFFECTS OF MATERNAL NICOTINE EXPOSURE AND TOMATO 
JUICE ON THE LUNG VOLUME (LV). 
Table 3.4 and figure 3.4 shows that the Lv of all the male and female animals; 
both the control and the experimental groups increased by 4 to 5-fold (P<0.001) 
between postnatal days 21 and 84.  
 
Up to postnatal day 42, the Lv of the control animals and the experimental 
groups, both male and female, increased at the same rate. The increase was 
such that at postnatal day 42, there was no difference in Lv between males and 
females as well as between the control and the experimental groups. However, 
after postnatal day 42, the Lv of the male nicotine group increased at a faster 
rate so that at postnatal day 84 it was 26.38% more (P<0.001) than that of the 
male control animals. There was no difference (P>0.2) observed between the Lv 
of the female control animals and that of the of the nicotine female group from 
postnatal day 21 to postnatal day 42. However, at postnatal day 63, the Lv of the 
control female animals was lower (P<0.003) than that of the female nicotine 
group. Interesting enough, at postnatal day 84, there was no difference (P>0.2) 
between the Lv of the female control animals and that of the female nicotine 
group. This indicates that from postnatal day 42, the Lv of the female nicotine 
group increased faster than the female control Lv. Thereafter, the increase 
slowed down so that on postnatal day 84, the Lv of the nicotine exposed animals 
was slightly but not significantly lower (P>0.05) than that of the control animals. 
 
 
 
 
58 
 
 
Table 3.4 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the Lung Volumes (Lv) (ml) of the males and female animals at postnatal days 
21, 42, 63, and 84. P-value: No differences within experimental groups up to day 42 (P > 0.05). 
From day 63 to day 84, C vs. N male is significant (P<0.05). On day C vs. N females is significant 
but not significant on day 84. 
Age 
(days) Sex Control  C vs. N Tomato C vs. T Nicotine C vs. N+T N+T 
21 Males 2.45±0.12 P>0.05 2.48±0.13 P>0.7 2.84±0.10 P>0.6 2.54±0.19 
Females 2.45±0.12 P>0.05 2.48±0.13 P>0.05 2.84±0.10 P>0.05 2.54±0.19 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 Males 5.95±0.40 P>0.1 5.37±0.29 P>0.2 5.05±0.33 P>0.3 5.43±0.40 
Females 5.33±0.23 P>0.8 5.09±0.37 P>0.5 5.28±0.27 P>0.9 5.31±0.24 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
63 Males 9.58±0.37 P<0.02 9.68±0.62 P>0.8 11.00±0.46 P>0.3 8.87±0.81 
Females 8.08±0.33 P<0.003 7.91±0.66 P>0.8 9.59±0.31 P>0.9 8.13±0.27 
M vs. F 
 P<0.008  P>0.07  P<0.001  P>0.2 
84 Males 11.22±0.29 P<0.001 11.86±0.37 P>0.2 14.18±0.64 P>0.09 11.18±0.33 
Females 10.42±0.40 P>0.2 9.66±0.71 P>0.3 11.14±0.55 P>0.1 9.45±0.36 
M vs. F 
 P>0.1  P<0.02  P<0.001  P<0.005 
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Figure 3.4 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the Lung Volumes (Lv) of the males and female animals at postnatal days 21, 42, 
63, and 84. 
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Table 3.5 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the Lv/BW (ml/g) ratio at postnatal days 21, 42, 63, and 84. P-value: No 
significant difference within experimental groups and within age groups from day 21 to day 84 
(P>0.05). 
Age 
(days) Sex Control  C vs. N Tomato C vs. T Nicotine C vs. N+T N+T 
21 
Males 6.05±0.26 P>0.3 6.81±0.27 P>0.05 6.37±0.19 P>0.05 6.86±0.33 
Females 6.05±0.26 P>0.3 6.81±0.27 P>0.05 6.37±0.19 P>0.05 6.86±0.33 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 
Males 4.26±0.21 P>0.5 4.40±0.18 P>0.6 3.96±0.40 P>0.1 3.83±0.20 
Females 4.09±0.15 P>0.7 4.56±0.32 P>0.1 4.00±0.36 P>0.2 4.32±0.14 
M vs. F 
 P>0.5  P>0.6  P>0.9  P>0.07 
63 
Males 3.57±0.16 P<0.001 3.98±0.33 P>0.5 4.22±0.21 P>0.7 3.58±0.37 
Females 3.90±0.21 P>0.3 4.31±0.37 P>0.1 4.45±0.12 P>0.1 4.40±0.22 
M vs. F 
 P>0.2  P>0.5  P>0.3  P>0.06 
84 
Males 3.40±0.10 P<0.02 3.51±0.15 P>0.3 4.22±0.14 P>0.9 3.45±0.09 
Females 4.54±0.20 P<0.03 4.06±0.26 P>0.3 4.84±0.20 P>0.1 4.11±0.16 
M vs. F 
 P<0.001  P>0.1  P<0.03  P<0.004 
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Figure 3.5 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the Lv/BW ratio at postnatal days 21, 42, 63, and 84. 
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Table 3.6 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the CC/Lv (mm/ml) ratio at postnatal days 21, 42, 63, and 84. P-value: No 
significant difference within experimental groups and within age groups from day 21 to day 84 
(P>0.05). 
Age 
(days) Sex Control C vs. N Tomato C vs. T Nicotine C vs. N+T N+T 
21 
Males 35.28±1.64 P>0.07 34.86±2.06 P>0.8 31.16±0.99 P>0.9 35.34±2.15 
Females 35.28±1.64 P>0.07 34.86±2.06 P>0.8 31.16±0.99 P>0.9 35.34±2.15 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 
Males 20.68±1.22 P>0.09 21.98±1.14 P>0.4 24.45±1.81 P>0.4 22.36±0.90 
Females 21.78±1.05 P>0.2 21.80±1.37 P>0.9 23.82±1.52 P>0.9 21.90±0.90 
M vs. F 
 P>0.4  P>0.9  P>0.7  P<0.9 
63 
Males 15.85±0.81 P<0.02 15.40±1.52 P<0.04 13.03±0.39 P>0.8 16.67±1.59 
Females 16.41±0.79 P<0.01 17.68±1.66 P>0.7 14.11±0.54 P>0. 6 16.21±0.64 
M vs. F 
 P<0.6  P>0.3  P>0.1  P>0.7 
84 
Males 14.16±0.29 P<0.001 13.30±0.36 P>0.09 11.61±0.34 P>0.6 13.89±0.47 
Females 13.52±0.61 P>0.2 15.49±1.25 P>0.2 12.72±0.37 P>0.09 15.25±0.69 
M vs. F 
 P>0.3  P>0.1  P>0.05  P>0.1 
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Figure 3.6 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the CC/Lv ratio at postnatal days 21, 42, 63, and 84. 
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Table 3.5 and figure 3.5 show that between postnatal day 21 and 42, there was 
no difference (P>0.05) between the Lv/BW ratios of the control animals and the 
experimental groups. On postnatal day 63, the Lv/BW ratios of the male control 
group was significantly lower (P<0.001) than that of the nicotine males, whilst the 
ratios between the control females and the nicotine females showed no 
difference (P>0.3). At postnatal day 84, however, both the male and female 
Lv/BW ratios of the control animals were significantly lower (P<0.05) than those 
of the male and female nicotine groups.  
 
Table 3.6 illustrates that at postnatal day 84, the CC/Lv ratios of the male control 
animals were higher than (P<0.001) than that of the nicotine male animals whilst 
the comparison between the control female animals and the nicotine female 
group showed no difference (P>0.2). In addition to that, there was no difference 
observed (P>0.05) between the CC/Lv ratios of the control animals and the 
CC/Lv ratios of the experimental animals. 
 
From the results obtained in tables 3.4, 3.5 and 3.6, it can be concluded that the 
maternal exposure to nicotine during gestation and lactation increases the lung 
volume of the male offspring born to these mothers. We can also deduce that the 
tomato juice has protective towards the adverse effects nicotine exerts on the 
lungs of the offspring when maternally administered together with nicotine. 
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3.4 THE EFFECTS OF MATERNAL NICOTINE AND TOMATO JUICE ON 
THE VOLUME DENSITY (VT) OF THE LUNG OF THE OFFSPRING. 
The data presented in table 3.7 and figure 3.7 demonstrates the volume density 
of the lung tissue (Vt) from postnatal day 21 up until postnatal day 84. The Vt of 
the of the control animals was higher (P<0.05) than that of the nicotine animals. 
The Vt of the control as well as that of the experimental animals exposed to 
tomato juice and to both nicotine and tomato juice increased with age so that the 
Vt at postnatal day 84 it was higher (P<0.001) than at postnatal day 21. From the 
data it was also evident that while the Vt of the control and the experimental 
groups increased with age, the Vt of the nicotine groups (both males and 
females) decreased (P<0.001) with age. From postnatal day 21 to postnatal day 
84, there were no differences (P<0.05) observed between the males and female 
animals within each group. 
 
The much lower values obtained from the day 63 and 84 nicotine treated group 
show the obvious destructive effects of nicotine on the lung parenchyma. In 
addition to this, it can be noted that the maternal intake of tomato juice combined 
with nicotine during gestation and lactation prevented the lungs of offspring of 
from the harmful effects of nicotine exerts on the developing rat lung. 
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Table 3.7 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the volume density % (Vt) of the parenchymal tissue of the male and female 
offspring at postnatal days 21, 42, 63, and 84. P-value: significant difference between C and N is 
evident from as early as day 21until day 84. P-value: No significant difference between C vs. T 
and C vs. N+T from day 21 to day 84 (P>0.05). 
Age 
(days) Sex Control  C vs. N Tomato 
C vs. 
T Nicotine C vs. N+T N+T 
21 
Males 20.19± 0.29 P<0.02 22.76± 1.13 P<0.01 18.77± 0.47 P>0.05 22.73± 0.75 
Females 20.19± 0.29 P<0.02 22.76± 1.13 P<0.01 18.77± 0.47 P>0.05 22.73± 0.75 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 
Males 22.73±0.49 P<0.01 23.50±0.30 P>0.2 17.81±1.11 P>0.3 23.28±0.25 
Females 24.64±0.58 P<0.001 23.17±0.70 P>0.1 17.27±0.66 P>0.2 22.84±1.33 
M vs. F 
 P>0.06  P>0.6  P>0.6  P>0.7 
63 
Males 26.17±1.13 P<0.002 27.65±0.30 P>0.9 14.70±1.18 P>0.8 25.79±1.13 
Females 25.08±0.33 P<0.003 27.54±0.43 P<0.01 15.79±1.49 P<0.02 23.77±0.09 
M vs. F 
 P>0.4  P>0.8  P>0.1  P>0.5 
84 
Males 28.69±1.52 P<0.001 28.52±1.00 P>0.9 15.85±0.27 P>0.3 26.78±1.19 
Females 26.45±0.57 P<0.001 27.81±0.91 P>0.2 15.25±0.09 P>0.9 26.34±1.37 
M vs. F 
 P>0.2  P>0.6  P>0.8  P>0.1 
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Figure 3.7 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the volume density the parenchymal tissue % (Vt) of the male and female 
offspring at postnatal days 21, 42, 63, and 84. 
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3.5 THE EFFECTS OF MATERNAL NICOTINE AND TOMATO JUICE ON 
ALVEOLAR LINEAR INTERCEPT (LM). 
The Lm measurement is an indication of the size of the alveoli. According to the 
data in table 3.8 and figure 3.8, the Lm of the 21 day old control animals was 
slightly but significantly higher (P<0.05) than that of all the experimental groups. 
However, from postnatal day 21 up to postnatal day 84, the Lm of the control 
animals gradually decreased so that on postnatal day 84, the Lm of the control 
animals were much lower (P<0.001) than that of the nicotine group. This is in 
contrast with the gradual increase in Lm of the nicotine exposed rats during the 
same period of time. 
 
The results obtained in table 3.8 and figure 3.8 are in agreement with the results 
obtained in table 3.7 and figure 3.7, showing that, the maternal exposure to 
nicotine during gestation and lactation will result in the gradual degradation of the 
lung tissue of the offspring. The maternal administration of tomato juice, together 
with nicotine during gestation and lactation, prevented the lungs of offspring of 
from the harmful effects of nicotine exerts on the developing rat lung. 
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 Table 3.8 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the linear intercept (Lm) (µm) of the male and the female offspring at postnatal 
days 21, 42, 63, and 84. P-value: significant difference between C and N is evident from day 21 
until day 84. P-value: No significant difference when C vs. T and C vs. N+T where compared from 
day 21 to day 84 (P>0.05). 
Age 
(days) Sex Control  C vs. N Tomato C vs. T Nicotine C vs. N+T N+T 
21 
Males 43.77±1.57 P<0.01 35.23±1.63 P>0.05 36.87±.075 P>0.05 38.90±1.47 
Females 43.77±1.57 P<0.01 35.23±1.63 P>0.05 36.87±0.75 P>0.05 38.90±1.47 
M vs. F 
 P>0.05  P>0.05  P>0.05  P>0.05 
42 
Males 32.27±1.47 P<0.04 29.97±1.32 P>0.2 49.55±7.07 P>0.8 35.19±1.56 
Females 32.20±1.34 P<0.001 33.39±0.82 P>0.2 40.97±0.35 P>0.4 32.67±2.19 
M vs. F 
 P>0.9  P>0.05  P>0.2  P>0.3 
63 
Males 32.97±1.76 P<0.004 36.12±1.41 P>0.3 44.73±2.79 P>1.00 33.09±1.76 
Females 33.00±1.79 P<0.01 35.10±1.08 P>0.9 46.07±3.09 P>1.00 30.95±1.79 
M vs. F 
 P>0.9  P>0.2  P>0.7  P>0.7 
84 
Males 32.97±0.99 P<0.001 32.56±0.83 P>0.4 46.77±2.20 P>0.6 33.79±0.74 
Females 33.65±1.80 P<0.001 32.13±2.16 P>0.7 47.50±2.17 P>0.6 34.18±0.56 
M vs. F 
 P>0.7  P>0.8  P>0.8  P>0.6 
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Figure 3.8 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the linear intercept (Lm) of the male and the female offspring at postnatal days 
21, 42, 63, and 84. 
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3.6 THE EFFECTS OF MATERNAL NICOTINE AND TOMATO JUICE ON 
INTERALVEOLAR SEPTAL THICKNESS (TSEPT) OF THE LUNGS OF 
THE OFFSPRING. 
The results of the Interalveolar septal thickness (Tsept) as shown in table 3.9 and 
illustrated in figure 3.9 shows that the Tsept of the nicotine group increased at a 
faster rate than that of the other groups so that on postnatal day 84, the Tsept of 
the nicotine groups was 71% higher (P<0.04) in the control males and 44% 
higher (P<0.04) in the control females. There was no difference (P>0.05) 
between the Tsept of the control and that of the tomato juice group and the group 
that was exposed to both nicotine and tomato juice at postnatal days 21 and 84. 
There was also no difference (P>0.05) in the Tsept of the male and female rats in 
the nicotine groups. 
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 Table 3.9 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the Interalveolar septal thickness (Tsept) (µm) of the male and the female 
offspring at postnatal days 21, 42, 63, and 84. P-value: No difference within experimental groups 
and within age groups from day 21 to day 63 (P>0.05). A significant difference between C and N 
is can be noted on day (P<0.05). 
Age 
(days) Sex Control  C vs. N Tomato C vs. T Nicotine C vs. N+T N+T 
21 
Males 9.27±1.20 P>0.4 7.22±0.70 P>0.1 8.08±0.90 P>0.1 6.91±0.95 
Females 9.27±1.20 P>0.4 7.22±0.70 P>0.1 8.08±0.90 P>0.1 6.91±0.95 
42 
Males 6.53±0.45 P>0.1 7.40±0.77 P>0.3 7.61±0.37 P>0.1 8.23±0.92 
Females 6.62±0.34 P>0.09 6.60±0.50 P>0.9 9.05±1.13 P>0.2 7.66±0.73 
63 
Males 7.36±0.83 P>0.2 8.50±0.96 P>0.4 9.77±1.45 P>0.6 7.36±0.83 
Females 8.96±1.50 P>0.5 9.90±1.80 P>0.7 10.33±1.28 P>0.8 9.55±2.02 
84 
Males 9.60±0.06 P<0.04 10.12±0.84 P>0.6 16.42±3.15 P>0.7 9.84±0.70 
Females 9.44±0.72 P<0.04 8.50±1.06 P>0.5 13.59±1.26 P>0.9 9.14±1.60 
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Figure 3.9 The effects of maternal exposure to nicotine, tomato juice, and both nicotine and 
tomato juice on the Interalveolar septal thickness (Tsept) of the male and the female offspring at 
postnatal days 21, 42, 63, and 84. 
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3.7 THE EFFECTS OF MATERNAL NICOTINE AND TOMATO JUICE 
EXPOSURE ON THE MORPHOLOGY OF THE LUNGS OF THE 
OFFSPRING. 
A view of the lungs of the 84-day-old animals as shown in figure 3.10 indicates 
that the control animals (A), the tomato group (B), and the N+T group (C), show 
the same architecture. These results are congruent to the results obtained from 
the morphometric results. The comparison of the control animals with the nicotine 
groups (D) demonstrates that on postnatal day 84, the nicotine group showed 
larger alveolar spaces compared to the control. The similarity between the 
control and the N+T group supports that the administration of tomato juice 
together with nicotine does have protective effects on the lungs of offspring that 
were maternally exposed to nicotine during gestation and lactation. 
 
3.8  THE EFFECT OF MATERNAL EXPOSURE TO NICOTINE AND 
TOMATO JUICE ON APOPTOSIS IN THE LUNGS OF THE 84-DAY-
OLD OFFSPRING. 
From fig 3.11 it appears as if the number of apoptotic cells were the same for the 
lung tissue of the 84-day-old rats of all the groups. However, when the volume 
densities of the apoptotic cells were determined (fig. 3.12) it was noted that the 
volume density of the apoptotic cells of the lungs of the 84-day-old control rats 
(27.90 ± 1.94 %) was lower (P<0.05) than that of the animals that were exposed 
to tomato juice (36.12 ± 1.98 %) or to a both nicotine and tomato juice (36.33 ±  
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Figure 3.10 The influence of maternal exposure to nicotine, tomato juice and a combination of 
nicotine and tomato juice on lung parenchyma of the 84-day-old offspring. A. = Control; B. = 
Tomato juice; C. = Nicotine + tomato juice; D. = Nicotine. 
Arrows = Emphysema.  (Bar = 0.5µm). 
A. B. 
C. D. 
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Figure 3. 11  The effect of maternal exposure during gestation and lactation to, A) nicotine, B) 
tomato juice only , C) control and tomato juice, or D) to nicotine only, on apoptosis in the lungs of 
84-day-old offspring. Arrows pointing some apoptotic cells. 
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Figure. 3. 12 The effect of maternal exposure to nicotine, tomato juice, or both nicotine and 
tomato juice on the volume density of the apoptotic cells of the lungs of the 84-day-old offspring. 
 
1.62 %). No difference was observed between the control and the animals that 
were exposed to nicotine only (28.54 ± 1.57 %). The Vt of the apoptotic cells of 
the nicotine group was lower than those that were exposed to tomato juice or to 
both nicotine and tomato juice. 
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CHAPTER 4 
  Discussion of Results 
4.1 INTRODUCTION 
Epidemiologic studies indicate that cigarette smoking is a major cause of COPD 
such as chronic bronchitis and emphysema (Morbidity and mortality weekly 
report, 1989). Cigarette smoke also contains abundant free radicals, including 
nitric oxide (Stedman, 1968), and may therefore induce some of its harmful 
effects by the free radical mechanism (Pryor et al, 1983). Reports indicate that 
approximately 20 to 30% of all newborns are exposed to components of tobacco 
smoke either before or after birth, increasing their susceptibility to respiratory 
diseases (Hofhuis et al, 2003). Several studies have indicated that reduced lung 
function caused by maternal exposure to cigarette smoke is predominant in the 
offspring of smoking mothers. The effects of maternal smoking during pregnancy 
on the offspring in utero and during postnatal life may persist even until the later 
stages of life (Cunningham et al, 1994). 
 
Some of the effects of maternal smoking include an increase the distance 
between alveolar attachment points onto small alveolar airways causing a 
decrease in the connection of the airways with the lung parenchyma (Elliot et al, 
2001). The adverse impact of maternal smoking on the alveolar airway-
parenchymal tethering may increase lung compliance and increase the 
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susceptibility of the respiratory system to COPD. Similarly, from studies done in 
rats, it was observed that the prenatal exposure to cigarette smoke not only 
decreased the number of pre-alveolar saccules but also increased their size, thus 
decreasing the number of attachment points on the small airways (Collins et al, 
1985). It is clear from the literature that, maternal smoking during prenatal 
development has major consequences on lung structure and function in early 
childhood as well as in the long-term (Maritz et al, 2005). Maternal smoking 
during gestation has been further demonstrated to accelerate deterioration of the 
forced expiratory volume (FEV1) which is suggestive of premature aging of the 
lung (Green and Pinkerton, 2004). These changes may compromise respiratory 
health in the long term. 
 
Cigarette smoke contains a range of radicals and oxidants which have the 
potential to increase the rate of oxidative damage. It is, therefore, conceivable 
that when the antioxidant defenses become overwhelmed by the oxidants, the 
resultant injury can lead to cell death. Some of the alterations of biological 
molecules brought about by cigarette smoke include oxidation of nucleic acids, 
cell proteins, and membrane lipids (Saha-Otterbein et al, 1998). These changes 
may results in accelerated cellular aging (Morla et al, 2006). 
 
Nicotine is a well recognized component of cigarette smoke (Perkins et al, 1994). 
It easily crosses the placenta to interact with nicotinic receptors in the lungs of 
the developing fetus (Sekhon et al, 1999). Nicotine has also been found in the 
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milk of smoking mothers (Luck and Nau, 1984; Page-Sharp et al. 2003). 
Furthermore, Rylander et al, (1995) found nicotine and cotinine in the urine of 10-
month-old non-suckling infants, indicating uptake of nicotine by passive smoking. 
Since the offspring in my study received nicotine only via the placenta and 
mother’s milk, the uptake of nicotine by the offspring in utero and during lactation 
was also passive.  
 
In a study by Benowitz et al (1982) and Murrin et al (1987) the plasma nicotine 
concentration was determined in female rats 2 days after birth of the offspring. 
These rats received 1.5 mg nicotine/kg body weight/day.They illustrated that the 
plasma nicotine content of these females rats were the same as that of human 
smokers. It is therefore, possible that in my study the increase in nicotine content 
of the mother’s milk after a single injection was initially of the same magnitude. It 
is known that pregnancy has variable and unpredictable effects on drug 
metabolism. It is, therefore possible that the plasma nicotine concentrations 
measured after birth are not likely to reflect the actual concentrations during the 
various stages of pregnancy, especially during critical windows of organogenesis. 
However, the immaturity of the antioxidant capacity of the fetal rat lung makes it 
vulnerable to the effects of nicotine from the mother’s blood and radical-mediated 
cell injury (Yam et al, 1978; Tanswell and Freeman, 1984; Gerdin et al, 1985; 
Hayashibe et al, 1990). Due to the slow metabolism of nicotine in the fetus, the 
half-life of nicotine will be much longer in the lungs of the offspring (Luck et al, 
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1985). This implies that the impact of nicotine on all those metabolic processes 
that are affected by nicotine, will last much longer than in the lungs of the adult. 
 
4.2 THE EFFECTS OF GENDER AND MATERNAL EXPOSURE TO 
NICOTINE, TOMATO JUICE AND TO BOTH NICOTINE AND TOMATO 
JUICE ON GROWTH AND DEVELOPMENT OF THE OFFSPRING. 
4.1.1 Gender differences 
It has been established from previous research that young male rats show a 
higher and more rapid increase in BW than do females from the same litter (Kim 
et al, 1952). The observation from the current study shows that from birth to 
postnatal day 42, there were no differences in BW between the males and the 
female animals within all the different groups. This means that growth up to 
postnatal day 42 was not affected by gender differences. On the other hand, the 
increase in body weight of male animals was faster between postnatal days 42 
and 84 than for the female animals. Kim et al (1952) suggested that the 
difference in the growth rate and ultimately weight of male and female animals 
may be due to a difference in the amount of food consumed or to the difference 
in the absorption and utilization of the food after it has been consumed.  
 
However, there is very little information available on whether the rapid increase in 
weight that is observed in the males is merely due to an elevated consumption of 
increase in male BW after postnatal day 42 can be attributed only to the intake of 
food compared to the females (Kim et al, 1952). It is unlikely that the faster 
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increase in male BW after postnatal day 42 can be attributed only to the intake of 
more food than the females because it is not a function of food intake only but of 
a variety of factors. The faster increase in BW in males is rather due to a 
physiological difference between males and females that comes into play at this 
stage of growth, development and maturation. It is plausible that the male rats 
continue to grow at the same rate but that the growth rate of the females slowed 
down as part of the physiologic maturation process, which includes hormonal 
changes related to gender differences. This is illustrated by the almost linear 
increase in BW of the male animals throughout the time of the study, while the 
female BW increase slowed down from after postnatal day 42. This suggestion is 
supported by studies of other researchers that proposed that one of the reasons 
for the difference in body weight is the release of gonadal steroids, which have 
been shown to have important effects on the regulation of energy balance. It is 
well known that androgenic hormones contribute significantly to the composition 
and control of BW (Gentry and Wade, 1976). The faster growth of the males is, 
therefore, most likely due to hormonal and metabolic changes that occur as part 
of their overall maturation. Due to this difference, males and females appear to 
have significant variations in the systems that regulate energy balance and body 
weight (Shi and Clegg, 2009). Woods and colleagues (1998) suggested that the 
regulation of body weight occurs through negative feedback mechanisms which 
characterize most systems. The catabolic signal to the brain is provided by the 
hormone leptin which is secreted from adipose tissue. Leptin controls body 
weight through the activation of the sympathetic nervous system (Campfield et al, 
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1995). It has been suggested that females have more subcutaneous fat than 
males (Dua, 1996). Since studies have shown that leptin levels are more 
associated with subcutaneous fat than visceral fat, it is conceivable that the 
adiposity message conveyed to the brain in males differs from that in females 
(Clegg et al, 2003 and 2006). According to Demerath et al (1999) females show 
higher leptin levels than males which will contribute to a lower food intake by the 
females compared to males. This is evident even before puberty. In addition, 
several studies have proposed that, estradiol which is one of the natural forms of 
estrogen, may also influence food intake and body weight regulation. Estradiol is 
involved in several physiologic functions that include development, growth and 
energy homeostasis (Houpt et al, 1979; Friend, 1971; Eckel et al, 2000; Czaja 
and Goy, 1975; Gong et al, 1989).  
 
This study is, among existing studies the first to show that the increase in BW of 
males and females is the same for up to 6 weeks after birth, and that the slower 
increase in the BW of the females only occurred around that time. It is interesting 
to note that male and female rats reach sexual maturity from 7 weeks after birth 
(Quin, 2005) and is conceivably the reason for the later onset of difference in the 
increase in BW between males and females. 
 
4.2.2 Effect of nicotine. 
Several studies have shown that fetal and neonatal nicotine exposure results in 
reduced body weight in rats during early postnatal life (Lawrence et al, 2008; 
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Cliver et al, 1995; Kramer, 1987). Some studies suggested that nicotine results in 
the constriction of placental blood vessels which consequently leads to a 
decreased placental blood flow. The nutritional supply to the fetus will, as a 
result, decrease during the period of vasoconstriction. This means that the 
exposure of the mother to nicotine during pregnancy could result in restricted 
fetal growth, resulting in lower birth weight of the offspring (Phillip et al, 1984; 
Birnbaum et al 1994). This is contrary to the findings of the present study, where 
no difference in BW was observed between the control and nicotine exposed 
offspring. It is possible that the doses of nicotine of 6 and 3 mg nicotine/kg body 
weight/day used by Phillip and co-workers (1984) and Birnbaum et al (1994) was 
too high. This is supported by the observations of Murrin et al, (1987) and 
Benowitz et al, (1982) that showed that when pregnant rats receive 1.5 mg 
nicotine per day, the maternal plasma nicotine concentration is similar to the 
values observed for human smokers. They showed that birth weight of the 
offspring and postnatal weight gain was not affected. It is, therefore, conceivable 
that the nicotine levels in my study were within the range of human smokers and 
conceivable that it will not affect the BW of the offspring. Also, since nicotine was 
given only once per day, it is possible that the time that placental 
vasoconstriction lasted, and thus the time of lower nutrient supply, was too short 
to have a significant impact on the growth of the offspring. 
The present study also demonstrated that neither maternal nicotine exposure nor 
intake of tomato juice during gestation and lactation had any effect on the chest 
circumference (CC) or the crown-rump length (CR) or on the CC/CR ratios. This 
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means that nicotine, as well as tomato juice had no effect on the proportional 
growth of the offspring. This means that all the changes seen in the lung 
structure of the offspring that was exposed to nicotine via the placenta and 
mother’s milk, was not due to an inadequate nutrient supply to the developing 
fetus and neonate. It is, therefore, conceivable that these changes can be 
attributed to the effects of nicotine or products of nicotine metabolism. 
 
4.3 THE EFFECT OF MATERNAL NICOTINE EXPOSURE ON LUNG 
DEVELOPMENT IN THE OFFSPRING. 
Apart from the BW, the results from this study further illustrated that from birth to 
postnatal day 42, there was no difference between the Lv of the male and female 
groups.  The results furthermore showed that between postnatal day 42 and 
postnatal day 84, the lung volumes (Lv) of the male nicotine group increased 
more rapidly compared to that of the females. The reason for the faster increase 
in the Lv of the male rats can be attributed to the bigger body weights and thus 
greater oxygen demand of the male rats due to faster growth from around 
postnatal day 42. This is supported by a study done by Gehr et al (1981) which 
showed that bigger animals require larger internal surface area in the lungs to 
meet the demands of the bigger body. Supporting studies indeed show that adult 
males have larger Lv than females (Becklake and Kauffman, 1999; Hyde et al 
2007; Thurlbeck, 1982), and that the increase in Lv is proportional to the increase 
in BW (Tenney and Remmers, 1963). These observations are supported by the 
data generated in this project, which shows that the Lv/BW ratios are the same 
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for male and female rats, except for the 84-day-old control male rats and those 
that were exposed to both nicotine and tomato juice, which was higher than that 
of the control female rats of the same age. This can be attributed to a faster 
increase in BW of the male rats between postnatal days 42 and 84.  
 
While maternal nicotine exposure had no effect on the lung volumes of the male 
rats up to postnatal day 42, the Lv of these rats increased faster after postnatal 
day 42 than that of the control male rats. Consequently, the Lv of these males 
was, at postnatal day 84, 26.4% higher than that of the controls. Contrary to this, 
the Lv of the control female and nicotine exposed rats was not affected by 
maternal nicotine exposure. This explains why the: 
1. Lv/BW ratio of the 84-day-old nicotine exposed male rats was 23.2 % 
higher than that of the control rats of the same age, and, 
2. CC/Lv ratio of the control rats of the same age was higher than that of the 
nicotine exposed rats. 
 
The reason for the different response of the male and female rats to maternal 
nicotine exposure is not known. It is possible that, the lungs of the males are 
more sensitive for the effect of nicotine. The bigger lung volume of the male 
nicotine exposed rats is conceivable due to higher lung compliance and not due 
to a larger chest circumference since the latter was not affected by maternal 
nicotine exposure. If this is so, it implies that the connective tissue framework of 
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the lungs of the male nicotine exposed rats was compromised. Studies to 
investigate this are currently planned. 
 
This above observation further implies that the lungs of the male nicotine 
exposed offspring will have a higher propensity for respiratory disease than the 
female rats that were exposed to nicotine via the placenta and mother’s milk. 
This observation is contrary to the findings of researchers who showed that 
female smokers have a higher risk of developing respiratory disease than males 
(Prescott et al, 1997; Patel et al, 2009). On the other hand, researchers in 
Australia and Japan showed that female smokers have lower incidences of 
COPD than male smokers (Sato et al, 2001; NSW Dept of Health, 2006) and 
supports the suggestion that males that were exposed to nicotine in utero and 
during lactation may have a higher propensity for respiratory disease than 
females The reason for the conflicting results is not known. The question that 
needs to be answered is whether or not in utero exposure to nicotine indeed 
elicits a different response in males and females in the long term. 
 
The Morphometric data shows that the alveolar diameter (Lm), and the alveolar 
volume of the lungs of the control rats, as well as the rats that were born from 
mothers that received tomato juice during gestation and lactation, decrease as 
the lungs mature. However, the alveolar volume of those rats that were exposed 
to nicotine via the placenta and mother’s milk increased as the animals age. This 
means that alveolar formation occurred in the control animals as opposed to the 
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gradual breakdown of alveolar walls in the lungs of the nicotine exposed 
offspring. The gradual breakdown of the alveolar walls resulted in the decrease in 
the tissue volume (Vt) of the lungs of the nicotine exposed rats as a function of 
age. This is in contrast to the increase in the Vt of the lungs of the control rats as 
well as those rats that were born to mothers that received tomato juice 
supplements, as well as those that received nicotine as well as tomato juice 
supplements. This slow increase in the Vt is a normal response of the lung to 
aging (Kovar et al, 2002).  
 
The decrease in Vt of the lung parenchyma of the nicotine exposed animals is to 
be expected because of the gradual deterioration of the lung parenchyma in 
these rats. The gradual deterioration of the lung parenchyma and the increase in 
alveolar volume, and consequently the reduced alveolar number, explains the 
decrease in the alveolar surface area available for gas exchange in the lungs of 
these rats. These observations were made for both the gender groups.  
 
In the light of the decrease in lung tissue volume of the nicotine exposed 
offspring, the increase in alveolar wall thickness (Tsept) of the lungs of these rats 
was unexpected. The fact that the tissue volume of these rats decreased despite 
the increase in alveolar wall thickness, was in all likelihood due to a faster 
deterioration of the lung parenchyma and the late onset of alveolar wall 
thickening. Consequently, the increase in alveolar wall thickness was masked by 
 
 
 
 
83 
 
this. The reason for the increase in alveolar wall thickness is not clear, but it can 
be due to: 
 
1. an increased production of extracellular matrix. 
The production of the extracellular matrix is tightly controlled. Since the 
connective tissue components, such as collagen and elastin, are important in 
maintaining the 3D structure of the lung, it is essential to ensure that a balance 
between synthesis and degradation is maintained. Epithelial-mesenchymal 
interaction is necessary to maintain this balance and thus alveolar integrity 
(Rehan et al, 2007). It has been shown that nicotine exposure in utero induces 
lung injury by disrupting the epithelial-mesenchymal control of extracellular matrix 
formation (Rehan et al, 2007). This may result in an imbalance in the 
homeostatic mechanisms that control the extracellular matrix content and 
composition of the lungs of these animals. In a study by Maritz and Thomas 
(1994) it was also shown that maternal nicotine exposure result in type I cell 
damage followed by type II cell proliferation and differentiation. They also 
showed that, in addition to the above, swelling of the mitochondria of these cells. 
This was not reflected in a slower oxygen utilization of the lungs which implies 
that it is unlikely that these cells were metabolically compromised (Maritz and 
Thomas, 1994). This means that the energy metabolism of the type II cells of the 
lungs of the nicotine exposed offspring was normal. The cell-cell interaction 
between type II cells and the fibroblasts will not be affected due to inadequate 
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energy metabolism, but rather if interaction between these two cell types is 
compromised.  
 
The composition of the extracellular matrix of the aging lung also changes. 
Studies by Huang et al (2007 a and b) showed that elastin fiber content decrease 
as the animals age while the collagen content increase. This will compromise the 
lung compliance as the animals age. It is plausible that the premature thickening 
of the alveolar walls of the lungs of the nicotine-exposed rats was due to a 
premature aging of the lungs, since aging of the lungs goes with a decline in 
homeostatic mechanisms involved in controlling extracellular metabolism and 
thus composition (MacNee, 2009). 
 
2.  an increase in the cellularity of the alveolar walls. 
An increase in the cellularity of the alveolar walls can be due to a) cell 
proliferation, or b) inhibition of apoptosis, or, c) both proliferation and suppression 
of apoptosis. 
 
a) cell proliferation 
Type II epithelial cell growth and differentiation is essential for the maintenance 
of lung alveolar integrity (Rehan et al, 2007). Mesenchymal-epithelial cell 
interactions are critically important for normal lung development as well as for 
repair of injury Shannon and Hyatt, 2004). It was suggested that due to the 
irreversible inhibition of glycolysis, the main energy source of the type I cells, it is 
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conceivable that it will result in death of the type I epithelial cells, followed by type 
II cell proliferation and differentiation to maintain alveolar integrity and thus 
internal surface area available for gas exchange (Maritz, 1987). They indeed 
illustrated an increase in the type II cell numbers of rats that were exposed to 
nicotine via the placenta and mother’s milk. These experiments were performed 
while the rat pups were still exposed to nicotine. Whether type II cell proliferation 
will still be enhanced after nicotine withdrawal is not known. If it is indeed 
enhanced, it is conceivable that the increase in alveolar wall thickness is due to 
an increased cellularity. No direct evidence is available yet to support such a 
suggestion. Whether that is true at this late phase of lung maturation is not 
known and warrant further study. 
 
b. a slower apoptotic process. 
Apoptosis plays an important role in lung development. According to Bruce et 
al (1999), the initial thinning of the alveolar walls during lung maturation, when 
the thick walled alveolar saccules are changed into thin walled alveoli, is due 
to apoptosis of the interstitial fibroblasts. Although epithelial type II cell 
proliferation occur when type I cell are damaged (Evans et al, 1975; Adamson 
and Bowden 1974), it has been shown that there is no correlation between 
cell proliferation and apoptosis (Imai et al, 2005). My results showed that 
maternal nicotine exposure during gestation and lactation result in 
microscopic emphysema in the adult rat. Cell-based mechanisms associated 
with emphysematous parenchymal damage include increased apoptosis and 
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cell proliferation. Apoptosis correlate with parenchymal deterioration and 
enlargement of airspaces in the aging lung (Imai et al, 2005). Although it is 
possible that apoptosis was affected by nicotine while the offspring was 
exposed to nicotine via the placenta and mothers milk, it had no effect on 
apoptosis in the lungs of the 84-day-old offspring. It is, therefore, unlikely that 
thickening of the alveolar walls of the 84-day-old rats as they age was due to 
a slower apoptosis or even increased cell proliferation. It can in all likelihood 
be attributed to an increase in the extracellular matrix. Further studies to 
investigate this are currently undertaken. 
 
It is important to note that some of the changes in the integrity of the lungs of 
the nicotine exposed offspring only become visible from around postnatal day 
42. The increase in alveolar wall thickness only became apparent around 
postnatal day 84. This means that these changes developed after all the 
nicotine was removed from the lungs of the offspring. It is therefore plausible 
that maternal nicotine exposure during lung development in utero and during 
early postnatal life, when cell proliferation and differentiation was rapid, 
induced changes to the “program” that controls lung development, 
maintenance of structural integrity and aging. Increased alveolar volume, 
thickening of alveolar walls and development of emphysema-like lesions in 
the lung parenchyma are all signs of lung aging. Since these structural 
changes occur in the lungs of the nicotine exposed offspring, it is a sign of 
premature aging of the lungs of these animals. 
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In summary, it noticeable from this study and from previous literature that the 
exposure to nicotine during gestation and lactation may result in the failure to 
maintain lung structure and functional integrity, as the animal gets older. The 
acceleration in the aging of the lung, however, implies that nicotine does alter the 
‘programming’ of the normal aging of the lung (Maritz et al, 2005). Premature 
aging of the lungs due to maternal nicotine exposure during gestation and 
lactation may render the fetal lungs more vulnerable to lung disease (Plummer et 
al, 2005). This premature aging is associated with a compromised antioxidant 
capacity of the mother and fetus. It is suggested that supplementing the mother’s 
diet with tomato juice rich in lycopene will prevent the change in the “program” 
and thus allow for a normal aging of the lungs of the offspring. 
 
4.4 THE ROLE OF TOMATO JUICE 
Maritz et al (2005) suggested that exposure to nicotine compromise the 
antioxidant capacity of the mother and that of the developing fetus and neonate. 
If this is so, strategies to normalize the antioxidant capacity of the mother and the 
fetus will prevent the adverse effects of maternal nicotine exposure on the 
“program” that controls lung maintenance and aging in the long term. One such 
strategy is to supplement the mother’s diet with tomato juice where tomato juice 
is rich in lycopene, a carotenoid, and other phytonutrients with strong antioxidant 
capacity (Rao and Argarwal, 1999). 
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Carotenoids have been documented to have antioxidant and preventative 
properties against free radical-induced cellular damage (Bendich, 1993). Several 
researchers have explored the potential function of antioxidant nutrients in the 
prevention of chronic diseases and the aging processes in humans (Mayne, 
2003). Lycopene is recognized as the main carotenoid in tomatoes (Kaplan, 
1990) and is further expected to be the most effective biological carotenoid in 
reducing or eradicating singlet oxygen (Di Mascio, 1989). The intake of dietary 
carotenoid may have the potential to influence the progress of tobacco smoke-
induced emphysema (Kasagi et al, 2006); given that tobacco smoke contains 
more than 1015 oxidant molecules/puff (Church, 1985). This is supported by the 
work of Kasagi et al (2006) who demonstrated that the combined use of tomato 
juice and chronic tobacco smoke exposure completely protected senescence-
prone mouse strain from smoke-induced emphysema. 
 
Tomatoes are the main dietary source of lycopene (Gerster, 1997). It has been 
indicated by previous researchers that at least 85% of our dietary lycopene 
comes from tomatoes and tomato based products such as juice, pastes, sauce 
and many more (Bramley, 2000). Markovic and colleagues (2006) found in their 
study that tomato extracts rich in lycopene was effective against oxidative stress. 
This means therefore, that tomato extract or lycopene may be effective against 
oxidative stress induced by chemicals or drugs to some organs. 
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Since nicotine induce oxidant activity in cells (Dasgupta et al, 2006), and since 
lycopene, a strong antioxidant (Rao and Argarwal, 1999),  is present in tomato 
juice (Takeoka et al, 2001; Kaplan et al, 1990), we decided to establish whether 
tomato juice will prevent the adverse effects of maternal nicotine exposure during 
gestation and lactation on lung development in the offspring.  
 
Supplementing the mother’s diet with tomato juice had no effect on the growth 
and development of the offspring. It also had no effect on the structural 
development of the lung. Tomato juice supplementation also prevented all the 
adverse effects of maternal nicotine exposure on lung development and aging in 
the offspring. It is likely that it will be effective in the prevention of the harmful 
effects of maternal smoking to the offspring of smoking pregnant women. This 
also suggests that tomato juice intake during gestation and lactation by smoking 
mothers, or mothers using nicotine replacement therapy to quit the habit, may 
prevent changes of the ‘program’ that controls lung maintenance and premature 
aging in the offspring. This will ensure an improved respiratory health in the 
offspring of smoking mothers. 
 
It is interesting to note that although maternal intake of tomato juice had no effect 
on lung growth and development or on the aging of the lungs of the offspring, it 
enhances apoptosis in the lungs of the 84-day old offspring. Whether apoptosis 
was faster during the earlier phases of lung development, while the offspring 
received lycopene and other phytonutrients via the placenta and mother’s blood, 
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is not known. Since apoptosis is still enhanced at day 84 after birth, that is 9 
weeks after tomato juice supplementation was terminated, implies that it has a 
long term effect on the offspring. The consequences of the enhanced apoptosis 
are not known. Since tomato juice supplementation during gestation and lactation 
had no effect on lung development and aging in the offspring at this late stage of 
lung maturation, it is not likely to have a detrimental impact on lung integrity and 
respiratory health. 
 
 4.5 CONCLUSION AND FUTURE PROSPECTIVES 
Studies show that despite all the efforts made by governments, researchers and 
communities to educate and inform women about the harmful effects of tobacco 
smoke and nicotine, smoking during gestation and lactation still remains a 
common habit and accounts for a significant percentage of fetal morbidity and 
mortality (Salihu and Wilson, 2007; Proskocil et al, 2005). The offspring is as a 
result exposed to nicotine through the blood and the milk of the mother (Luck and 
Nau, 1984). The results in this project support the findings in previous studies 
that showed that maternal exposure to nicotine during gestation and lactation 
alters the "program" that controls the maintenance on the lung structure in the 
long term (Maritz and Windvogel, 2003). 
 
The present study further suggests that maternal nicotine exposure during 
gestation and lactation result in premature aging of the lungs of the offspring. 
This will increase the risk of respiratory disease in the adult. Furthermore, the 
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data from the present study showed that maternal supplementation with tomato 
juice prevents all the adverse effects of maternal nicotine exposure. Further 
studies are essential to further investigate the mechanism of action of nicotine 
and to refine develop strategies to prevent the adverse effects of smoking and 
nicotine on lung development of the offspring. These include: 
1. Assessing cell senescence in the lungs of the offspring  
2. determine the reason for alveolar wall thickening 
3. establish why tomato juice enhance apoptosis and the long term outcome 
of it. 
 
In conclusion, it is apparent from this study that the nicotine intake during 
pregnancy and lactation presents harmful effects on the health and development 
of the fetal lung. The present study determined the effects of maternal nicotine 
exposure during gestation and lactation on lung development in the offspring. 
The study also established that the consumption of tomato juice may have 
protective effects on the premature aging of the lungs of the offspring. 
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